Maintenance of Interstitial Cells of Cajal for Intestinal Smooth Muscle Engineering by Kobayashi, Masae
UCLA
UCLA Electronic Theses and Dissertations
Title
Maintenance of Interstitial Cells of Cajal for Intestinal Smooth Muscle Engineering
Permalink
https://escholarship.org/uc/item/54q8x8xq
Author
Kobayashi, Masae
Publication Date
2016
Supplemental Material
https://escholarship.org/uc/item/54q8x8xq#supplemental
 
Peer reviewed|Thesis/dissertation
eScholarship.org Powered by the California Digital Library
University of California
 
 
UNIVERSITY OF CALIFORNIA 
 
Los Angeles 
 
 
 
 
 
 
 
 
 
 
Maintenance of Interstitial Cells of Cajal 
 
for Intestinal Smooth Muscle Engineering 
 
 
 
 
 
 
 
 
A dissertation submitted in partial satisfaction of the 
 
requirements for the degree Doctor of Philosophy 
 
in Bioengineering 
 
 
 
 
by 
 
 
 
 
Masae Kobayashi 
 
 
 
 
2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by 
 
Masae Kobayashi 
 
2016 
ii 
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University of California, Los Angeles, 2016 
 
Professor James C.Y. Dunn, Chair 
 
 
 
 
Interstitial cells of Cajal (ICC) are the pacemakers that enable the oriented intestinal 
smooth muscle layers to contract rhythmically and autonomously. However, disruption of ICC 
networks has been reported in various intestinal motility disorders, which deteriorate the quality 
of life and life expectancy of a growing number of people in recent years. The key challenges in 
current intestinal smooth muscle engineering are the rapid loss of functional ICC and smooth 
muscle cells (SMC) in the culture. The objective of this study was to engineer functional 
intestinal smooth muscle with proper alignment and spontaneous rhythmic contraction by 
overcoming those obstacles. This was achieved by 1) developing orthogonally oriented scaffolds 
with aligned fibers for engineering intestinal smooth muscle in vivo; 2) identifying a 
reproducible culture system for in vitro maintenance of isolated ICC with pacemaker activity; 
and 3) engineering intestinal smooth muscle constructs with directional rhythmic contractions by 
implementing the functional ICC culture system into aligned scaffolds.  
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In summary, this research yielded reproducible practices using a simple feeder cell 
system for in vitro expansion of isolated ICC, which enabled the development of structurally 
desirable intestinal smooth muscle constructs exhibiting spontaneous membrane potential 
oscillations and contractions over 10 weeks in vitro. The demonstrated work not only contributed 
to the progress of intestinal tissue engineering, but also may provide valuable information for 
research in intestinal motility disorders, and for other types of visceral smooth muscle 
engineering including the bladder and vascular system. 
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CHAPTER ONE: INTRODUCTION 
1.1 GASTROINTESTINAL TRACT DISORDERS 
The intestine is part of our essential gastrointestinal (GI) tract, responsible for digestion, nutrient 
and water absorption and waste removal. Unfortunately, an increasing number of people are 
suffering from various intestinal disorders. According to Crohn’s and Colitis Foundation of 
America, there are approximately 1.6 million Americans suffering from inflammatory bowel 
disease (IBD) in 2014. This is a 0.2 million increase in six years from 1.4 million IBD patients in 
2008. Moreover, the American Cancer Society reported that the lifetime risk of developing 
colorectal cancer is about 5% and is the second leading cause of cancer-related deaths in the 
United States as of 2014. According to the International Foundation for Functional 
Gastrointestinal Disorders, children are diagnosed with common disorders like functional 
abdominal pain, chronic constipation, and irritable bowel syndrome at a rate similar to adults, 
which is 10% to 20%. In addition, Hirschsprung’s disease, a congenital disorder associated with 
missing enteric nerve cells in part or all of the colon, occurs in about 1/5000 live births. 
In some cases of the diseases listed above, surgery intervention is required. However, 
short bowel syndrome occurs in a patient when half or more of the bowel is removed during 
surgery or due to a birth defect. As a result, there may not be enough surface area in the bowel to 
absorb enough nutrients from food. Current treatments such as total parenteral nutrition (TPN) 
and transplantation have their own limitations. Patients who are dependent on TPN tend to 
experience severe liver complications while transplantation has common problems including 
donor scarcity, transplant rejection and life-long immunosuppression1. Therefore, engineering 
functional intestinal muscle tissues raises hope as an alternative therapeutic strategy for GI tract 
disorders. 
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1.2 INTERSTITIAL CELLS OF CAJAL (ICC): PHENOTYPES AND ROLES 
The aligned smooth muscle layers of the GI tract move autonomously. Spontaneous electrical 
slow waves derived from pacemaker activity of the GI tract arrange contractile patterns into 
phasic contractions that are the root for peristalsis. GI muscles exhibit intrinsic pacemaker 
activity that does not depend on neural or hormonal inputs, while the degree of coupling between 
pacemaker activity and contractions is highly dependent on neural and other regulatory inputs. 
Basal spontaneous slow wave activity displays low amplitude contractions, and inhibitory or 
excitatory neural inputs modulate the amplitude2. 
ICC are a specialized group of cells involved in smooth muscle excitability that are 
mesenchymal in origin3–5. ICC play critical roles in visceral smooth muscles, including acting as 
electrical pacemakers to control phasic contractile activity and as mediators in motor 
neurotransmission. ICC have few contractile elements but contain abundant mitochondria, 
endoplasmic reticulum and caveolae for intracellular and extracellular calcium handling, and 
distinct membrane channels for their specialized functions as pacemakers and neuromodulators6. 
ICC have various morphologies in different locations of the GI tract. For example, ICC in the 
myenteric region (ICC–MY) are typically multipolar cells making frequent gap junctions with 
each other and forming an electrical network and closely associating with the enteric nervous 
system 7–10, whereas ICC within the muscles are long, thin, bipolar cells with few processes 
extending out to track along the axons of enteric motor neurons7,8,10.   
The binding of stem cell factor (SCF) to the receptor tyrosine kinase (Kit) induces a 
signaling pathway in ICC, which is critical for the normal development of ICC and rhythmic 
activity in the GI tract11–15. SCF stimulation of Kit is essential for ICC maintenance, as ICC 
vanish upon addition of neutralizing Kit antibody (ACK2) 14,16. In addition, animals with 
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mutated Kit or SCF demonstrated disruption of the ICC-MY network in the small intestine and 
loss of the spontaneous electrical slow wave and contractile activity 11,17–20. Moreover, ICC-MY 
display large amplitude electrical slow waves and are known for its pacemaker activity21,22. 
Recently, Ca2+ activated Cl–  channels (ano1) expressed on ICC were identified as the key 
conductance responsible for the pacemaker activity. Depolarization in ICC triggers slow waves 
with properties of Ca2+ activated Cl–  current.  Slow waves propagate actively by depolarization-
induced activation of low-threshold, voltage-dependent Ca2+ channels (ano1) that facilitate Ca2+ 
entry into ICC and induce Ca2+ release. These currents and slow waves were blocked by niflumic 
acid (a molecule that inhibits Cl–  channels)23.  Transgenic mice with deactivated Tmem16a, a 
gene coding ano1, demonstrated normal morphological ICC networks but no slow waves24.  
Furthermore, ICC have the receptors required for transduction of neurotransmitter signals25,26.  
Prejunctional and postjunctional synaptic proteins exist at the interface between ICC and enteric 
varicosities27 . Gap junctions exist between ICC and SMCs28–30, though only few and small 
junctions are observed  between ICC-MY and SMCs31. Activation of Ca2+ activated Cl– channels 
in ICC generates inward currents leading to slow waves. Slow waves travel to SMCs forming 
cycles of depolarization that can activate Ca2+ channels and link slow waves to smooth muscle 
contractions2. ICC supply a pathway for the active propagation of slow waves, which enables the 
coordination of organ-level propagation of contractions leading to peristalsis2. Therefore, 
continuous networks of ICC are essential to engineer a GI tract with phasic electrical and 
mechanical activity. 
Loss or disruption of ICC networks in GI muscles have been reported in a variety of 
intestinal motility disorders, including achalasia, chronic intestinal pseudoobstruction, 
Hirschsprung’s disease, inflammatory bowel diseases, slow transit constipation, and diabetes32–
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36. Therefore, it is crucial to incorporate ICC in order to engineer functional intestinal smooth 
muscles. 
 
1.3 FEEDER CELLS FOR ICC CULTURE 
Isolated intestinal SMCs do not typically generate rhythmic electrical slow waves. Individual 
SMCs can possibly generate fast Ca2+ action potentials, but not the spontaneous slow waves in 
GI muscles. Conversely, isolated ICC generate spontaneous electrical rhythmicity similar to the 
electrical activity in intact GI muscles23,37. However, ICC only comprise less than 10% of total 
cells within intestinal smooth muscle layers and isolated ICC are hard to maintain in in vitro cell 
culture. ICC tend to lose their characteristic morphologies and Kit immunoreactivity after 
enzymatic digestion during the single cell isolation procedure. Although ICC have managed to 
grow and develop networks and electrical rhythmicity in cell culture, those dispersed ICC 
undergo extensive phenotypic changes within a few days, including the apparent loss of the ion 
channels responsible for the slow wave activity 23,38,39. Since adequate Kit-SCF signaling is 
required for ICC proliferation and maturation, ICC were grown on fibroblast cell lines 
genetically engineered to express SCF. This study demonstrated that the number of Kit-positive 
ICC increased significantly when cultured with SCF expressing fibroblasts than with fibroblasts 
with no SCF expression40. However, all the ICC analyses were performed after only 48 hours in 
culture in this study because other types of cells overpopulated if cultured longer. Also, 
preparing SCF expressing fibroblasts by genetic modification may add another variable to the 
control in the culture system because the degree of SCF expression may vary from each 
preparation and may take a long time to acquire a stable and repeatable system. Therefore, it is 
beneficial to identify suitable SCF expressing feeder cells that are easily obtainable and 
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beneficial for in vitro ICC expansion. To my knowledge, no one has been able to expand 
functional ICC in in vitro culture for over a week with intact pacemaker activity. It will be 
crucial to the progress in intestinal smooth muscle engineering if suitable feeder cells can be 
identified for the in vitro expansion of functional ICC. 
 
1.4 DISSERTATION OBJECTIVES AND SPECIFIC AIMS  
The small and large intestines are part of our essential gastrointestinal (GI) tract and function to 
enhance the absorption of nutrients and water, and excretion of waste through synchronized 
peristalsis. However, many people are suffering from various intestinal disorders. For instance, 
over 1.5 million Americans are currently diagnosed with inflammatory bowel disease. As of 
2014, colorectal cancer is the second leading cause of cancer-related deaths in the United States, 
and approximately 5% of people are at the risk of developing it. The essential GI motility can be 
disturbed due to disease, damage, surgical or obstetric trauma, and age. Some examples of 
congenital defects of GI motility are Hirschsprung’s disease, intestinal pseudoobstruction, and 
achalasia41. However, currently available pharmacologic treatment and surgical correction does 
not provide a long term solution for those motility disorders.  Therefore, tissue engineering is 
investigated in hope to regenerate the specific GI layers with proper architecture and 
functionality. 
Aligned layers of smooth muscle in the GI tract move autonomously. However, this is not 
due to smooth muscle cells (SMCs) but cells called interstitial cells of Cajal (ICC). ICC are a 
specialized group of cells involved in smooth muscle excitability that are mesenchymal in 
origin3–5. ICC play critical roles in visceral smooth muscles, including acting as electrical 
pacemakers to control phasic contractile activity and as mediators in motor neurotransmission. 
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Loss or disruption of ICC networks in GI muscles has been reported in a variety of intestinal 
motility disorders. Extensive study has been performed to understand ICC physiology, yet no 
study has reported culturing ICC in vitro for tissue engineering purpose. Therefore, integration of 
the ICC population is an essential step in engineering functional intestinal smooth muscles.  
The main challenges in current intestinal smooth muscle engineering are 1) in vitro 
expansion of functional ICC, 2) in vitro expansion of functional SMCs, and 3) the lack of 
structurally desirable implant with proper cell distribution and alignment. Dissertation objectives 
were set to address the challenges by completing the following three specific aims: 
Aim 1: Develop orthogonally oriented scaffolds with aligned fibers for engineering 
intestinal smooth muscle in vivo. Rationale. Scaffold alignment has been used to induce cell 
alignment in previous studies 42–46. In this aim, two-layer ePCL scaffolds with orthogonally 
aligned fibers were implemented to mimic tissue orientation of intestinal circular and 
longitudinal smooth muscle layers. The viability and alignment of cells infiltrated into the ePCL 
scaffolds in vivo was evaluated using ventral subcutaneous implantation into mice. At the 
conclusion of this aim, implants with desirable alignment that mimic the native intestinal muscle 
layers were developed.  
Aim 2: Identify a reproducible culture system for in vitro maintenance of isolated 
ICC with pacemaker activity. Rationale. ICC isolated from small intestine are hard to maintain 
in in vitro cell culture. In this aim, optimization of the isolation, purification and identification 
techniques to acquire viable isolated ICC in vitro was accomplished initially. The effect of feeder 
cells to maintain ICC phenotype and the pacemaker activity in vitro was evaluated. At the 
conclusion of this aim, a reproducible protocol to in vitro culture primary isolated ICC with 
proper phenotypes and functionality was identified. 
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Aim3: Engineer intestinal smooth muscle constructs with directional rhythmic 
contractions by implementing the functional ICC culture system into aligned scaffolds. 
Rationale. ICC plays an important role as pacemaker cells for intestinal smooth muscles to 
perform proper peristalsis.  Loss of ICC in intestinal muscle layers often results in intestinal 
dysmotility. From the tissue engineering perspective, expanded ICC meet their ultimate role 
when they can restore the motility of SMCs. Using an optimized ICC culture system, intestinal 
SMC mixtures containing ICC, SMCs and neuronal cells were seeded onto aligned ePCL 
scaffolds.  The effect of functional ICC to induce spontaneous rhythmic contractions of SMCs 
was evaluated. At the conclusion of this aim, smooth muscle constructs with rhythmic 
contractions and directionality was engineered. 
In summary, this research 1) yielded reproducible practices for in vitro expansion of 
isolated ICC and 2) developed a structurally desirable implant that mimics intestinal 
smooth muscle layers 3) with spontaneous membrane potential oscillations and 
contractions. 
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CHAPTER TWO: ORTHOGONALLY ORIENTED SCAFFOLDS WITH ALIGNED 
FIBERS FOR ENGINEERING INTESTINAL SMOOTH MUSCLE 
2.1 ABSTRACT 
Controlling cellular alignment is critical in engineering intestines with desired structure and 
function. Although previous studies have examined the directional alignment of cells on the 
surface (x-y plane) of parallel fibers, quantitative analysis of the cellular alignment inside 
implanted scaffolds with oriented fibers has not been reported. This study examined the cellular 
alignment in the x-z and y-z planes of scaffolds made with two layers of orthogonally oriented 
fibers. The cellular orientation inside implanted scaffolds was evaluated with 
immunofluorescence. Quantitative analysis of coherency between cell orientation and fiber 
direction confirmed that cells aligned along the fibers not only on the surface (x-y plane) but also 
inside the scaffolds (x-z & y-z planes). Our study demonstrated that two layers of orthogonally 
aligned scaffolds can generate the histological organization of cells similar to that of in- testinal 
circular and longitudinal smooth muscle. 
 
2.2 INTRODUCTION 
In the small intestine, the inner circular smooth muscle layer is orthogonally oriented to the outer 
longitudinal smooth muscle layer, and the myenteric plexus is embedded between these layers. 
The arrangement of smooth muscle cells, neural cells and interstitial cells of Cajal within the 
intestinal smooth muscle is highly organized in order to coordinate peristalsis [1]. In other tissues 
such as the vasculature [2,3], myocardium [4], skeletal muscle [5], nervous system [6,7], and 
connective tissues [8,9], cellular alignment is also essential for their proper function. It is 
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therefore desirable to replicate the native microstructures and cellular alignment for tissue 
engineering constructs. 
Electrospun scaffolds with aligned fibers have been explored for their suitability to align 
cells in many tissue engineering applications [5,10–13]. Various synthetic and biological 
polymers have been electrospun to fabricate scaffolds with desired fiber size and alignment 
[14,15]. These fibers replicate the length scale of elements in the native extracellular matrix and 
promote cellular differentiation and matrix production [16,17]. Aligned fibers can be fabricated 
by collecting elecrospun fibers on rotating mandrels, leading to controllable mechanical and 
structural anisotropy [5,12,18,19]. Among a variety of FDA approved polymers, poly(3-
caprolactone) (PCL) is a promising material due to its biocompatibility, biodegradability and 
mechanical properties. Fibrous scaffolds composed of PCL are 10 times less stiff and stay elastic 
over a wider range, as compared to scaffolds made of poly(D,L-lactic- co-glycolic acid 50:50) 
[20]. Electrospun PCL (ePCL) scaffolds with aligned fibers were shown to enhance cellular 
alignment, matrix deposition, and increased tensile properties along the fiber direction when 
compared to similar scaffolds with randomly oriented fibers [5,21]. Such flexibility and 
controllable directionality of ePCL scaffolds make it a suitable choice for muscle tissue 
engineering. 
Previous studies have examined the cellular alignment on the 2D surface (x-y plane) of 
cells in culture [2,5–9,22], but the alignment of cells inside 3D scaffolds in vivo  has not been 
analyzed quantitatively. We hypothesized that a two-layer ePCL scaffold with orthogonally 
aligned fibers would generate 3D cellular alignment analogous to the intestinal circular and 
longitudinal muscle layers. In this study, we compared the cellular alignment in the x-z and y-z 
planes of implanted ePCL scaffolds made with either aligned or randomly oriented fibers. 
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2.3 MATERIALS AND METHODS 
2.3.1 Electrospinning  
11% (w/w) solution of PCL (Durect Lactel, Birmingham, AL) was made in hexafluoro-2-
propanol (Acros Organics, Thermo Fisher Scientific, Waltham, MA). The solution was kept on a 
shaker overnight to obtain a homogenous polymer solution. The mandrel was wrapped with 
aluminum foil to ease the removal of the scaffold. The PCL solution was transferred to a plastic 
syringe fitted with an 18-gauge needle, and secured onto a syringe pump (Harvard Apparatus, 
Holliston, MA). The solution was infused at 2.5 ml/h onto a rotating mandrel collector with an 
outer diameter of 32 mm that was positioned 12-15 cm away from the needle tip. The electrical 
potential difference between the needle (i.e., polymer solution) and the grounded mandrel 
collector was produced by a high voltage power supply (Glassman High Voltage, High Bridge, 
NJ). Scaffolds comprised of aligned ePCL fibers were fabricated using a mandrel rotational 
speed of 3450 rpm and an applied voltage of 15 kV. Less-aligned, “random” ePCL fibers were 
produced using a mandrel rotational speed of 1725 rpm and applied voltage of 25 kV. After 0.5 
ml of polymer solution had been dispensed from the syringe onto the rotating mandrel, the ePCL 
was carefully removed from the aluminum foil. Scaffolds were air-dried before laser cutting 
(Fig. 1A). 
 
2.3.2 Scanning Electron Microscopy (SEM) 
The surface morphology of ePCL scaffolds with aligned or random fibers was assessed using a 
Nova NanoSEM 230 (FEI, Hillsboro, Oregon). The scaffolds without conductive coating were 
mounted on the sticky conductive carbon tape (Ted Pella, Redding, California ) on the top of 
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aluminum stubs (Ted Pella, Redding, California ) and examined under SEM with an accelerating 
voltage of 10 kV at low vacuum mode. 
 
2.3.3 Laser cutting 
The ePCL scaffolds were constructed as fiber sheets with dimensions approximately 10 x 2.5 cm 
and thickness of 100-150 µm, based on the mandrel used. These fiber sheets were cut into 
rectangular 8 x 6.5 mm scaffolds using the VERSA LASER CUTTER 2.3 (Universal Laser 
Systems, Scottsdale, AZ) with vector mode, 5% power, 100x speed, and 1000 pulses/inch. Two 
types of scaffolds were obtained by setting the longer or shorter edge of the rectangle to be along 
the fiber direction (Fig. 1B). The scaffolds were sterilized in 70% ethanol for 30 min and washed 
several times with phosphate buffered saline (PBS). 
 
2.3.4 Ethics statement 
Animal usage complied with regulations set by the University of California, Los Angeles, 
Chancellor’s Animal Research Committee and was approved as animal protocol number 2005-
169. All efforts were made to minimize pain and suffering. Two mice strains were used for these 
experiments: C57BL/6-Tg(Actb-EGFP)1Osb/J (“GFP”) (The Jackson Laboratory, Bar Harbor, 
ME) and wild type C57BL/6 (Charles River, Wilmington, MA). 
 
2.3.5 Intestinal smooth muscle strips (SMS) isolation and culture 
SMS were isolated from two 7 to 8-day-old GFP-positive C57BL/6 neonates using previously 
described methods [23–25]. The intestines were removed via a midline incision, and smooth 
muscle strips, containing both longitudinal and circular muscle layers, were gently teased from 
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the intestines using fine forceps and placed in Hank’s Balanced Salt Solution without calcium 
and magnesium (Invitrogen, Carlsbad, CA) on ice. SMS were minced thoroughly using a scalpel. 
Approximately one-tenth of the SMS were seeded directly to each ePCL scaffold, which was 
coated with gelatin solution (attachment factor solution; Invitrogen, Carlsbad, CA) at 37°C for at 
least 30 min and briefly washed with PBS once in advance. SMS-seeded ePCL scaffolds were 
cultured at 37°C in a 5%CO2 incubator in Knockout™ D-MEM supplemented with 15% FBS, 
0.1 mM 2-mercaptoethanol, 0.1mM non-essential amino acids (NEAA), 2mM L-glutamine, and 
1x antibiotic-antimycotic (all from Invitrogen, Carlsbad, CA). The medium was changed after 2 
days to the same medium but without antibiotic-antimycotic. SMS-seeded ePCL scaffolds were 
incubated in vitro for approximately 3 weeks before implantation to allow infiltration of cells 
inside the scaffolds. The SMS-seeded sides of two ePCL scaffolds were connected together to 
form a two-layer scaffold with 10 µL of collagen gel (PureCol® EZ Gel, Advanced BioMatrix, 
San Diego, CA) right before implantation (Fig. 1E-H). 
 
2.3.6 Scaffold Implantation 
ePCL scaffolds with or without cells were implanted subcutaneously into syngeneic wild type 
adult C57BL/6 mice. Recipient mice were anesthetized with inhaled isoflurane and given a 
subcutaneous injection of 0.05 mg/kg buprenorphine. The abdomen was shaved, prepared, and 
draped sterilely. A ventral midline incision was made and skin flaps were raised laterally to 
create subcutaneous pockets. The ePCL scaffolds were sutured to the abdominal wall using 6-0 
Prolene suture (Ethicon, Somerville, NJ), and the incision was closed using 3-0 silk suture 
(Ethicon). Recipient mice with SMS-seeded scaffolds were sacrificed approximately 4 days 
postoperatively while recipient mice with scaffolds without initial SMS seeding were sacrificed 
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approximately 2 weeks postoperatively. The explants were formalin-fixed and processed for 
histological evaluations. 
 
2.3.7 Histology & immunofluorescence staining 
In vivo explants were fixed and processed for paraffin embedding. Serial 5-µm sections were cut 
and adhered to glass slides; every third slide was stained with hematoxylin and eosin (HE). 
Unstained slides were prepared for immunofluorescence staining. Slides were de-waxed with 
xylene and rehydrated with serial dilutions of ethanol. Next, slides were incubated in a citric 
buffer (Biogenex, San Ramon, CA) for 15 min at 95-100°C and allowed to cool for 15 minutes 
in an over flowing water bath. In vitro cultures were fixed without histologic processing. After 
three washes with PBS, samples were treated with blocking buffer containing 5% normal goat 
serum (Vector Labs, Burlingame, CA), 0.1% Triton X-100 (Sigma) in PBS for 1 hour at 4°C. 
Samples were then incubated with primary antibodies against alpha smooth muscle actin (α-
SMA) (1:250; Dako, Carpinteria, CA) and green fluorescent protein (GFP) (1:1000, Abcam, 
Cambridge, MA) diluted in blocking buffer overnight at 4°C. After two washes in PBS, samples 
were incubated in the dark with their corresponding secondary antibodies (goat anti-mouse Alexa 
Fluor 488, goat anti-rabbit Alexa Fluor 596, Invitrogen) diluted at 1:1000 in blocking buffer for 
2 hours at room temperature. After three washes with PBS, Prolong Gold with DAPI (Invitrogen) 
was applied to each section and the slides were covered with glass coverslips. Then, slides were 
allowed to cure at 4°C before storing at -80°C. Images were acquired with an Olympus IX71 
microscope with cellSens software (Olympus, Center Valley, PA). 
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2.3.8 Quantification of cellular alignment inside ePCL 
Immunofluorescence of α-SMA and GFP was used to assess the alignment of cells within the 
ePCL scaffold. The alignment measurement was carried out with the NIH ImageJ software plug-
in named OrientationJ to calculate the directional coherency coefficient [26]. The coherency 
coefficient ranges from 0 to 1, with 1 indicating a strongly coherent orientation or for this study, 
greater cellular alignment. To assess the fiber orientation of bare ePCL scaffolds, 3 sample areas 
were captured. To assess the cell orientation on the surface of the ePCL scaffold under in vitro 
culture, 3 sample areas were captured for both α-SMA and GFP immunostaining. The alignment 
of cells inside the ePCL scaffold was evaluated at the following four experimental 
configurations: (1) aligned ePCL scaffold without SMS seeding, 2 weeks in vivo. Approximately 
100 sample areas of 6 scaffolds from 4 different animals were analyzed. (2) random ePCL 
scaffold without SMS seeding, 2 weeks in vivo. Approximately 140 sample areas of 4 scaffolds 
from 2 different animals were analyzed. (3) aligned ePCL scaffold with SMS seeding, 3 weeks in 
vitro culture followed by 4 days in vivo. Approximately 200 sample areas of 6 scaffolds from 3 
different animals were analyzed for α-SMA expression and 43 sample areas of 3 scaffolds from 3 
different animals were analyzed for GFP expression. (4) random ePCL with SMS seeding, 3 
weeks in vitro culture followed by 4 days in vivo. Approximately 140 sample areas of 4 scaffolds 
from 2 different animals were analyzed for α-SMA expression and 55 sample areas of 3 scaffolds 
from 2 different animals were analyzed for GFP expression. For each condition, sample areas 
were grouped into the upper or lower layer of the x-z or y-z plane and their coherency were 
compared (Fig. 1E-H). 
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2.3.9 Statistical Analysis 
Two-tailed unpaired Student’s t-test was used to compare the results from the image analysis. A 
level of significance was set at p < 0.01. Data were expressed as the mean ± the standard 
deviation (SD). 
 
2.4 RESULTS 
2.4.1 Two-layer Scaffolds 
The intestinal circular and longitudinal smooth muscle layers are orthogonally arranged relative 
to each other (Fig. 1C,D). To mimic this native histological organization, we employed two 
layers of ePCL scaffolds with aligned fibers seeded with or without SMS. Scaffolds with 
randomly oriented fibers seeded with or without SMS were used as comparisons. Two layers of 
the ePCL scaffolds were assembled from either aligned or randomly oriented fibers by adding 
collagen gel between two sheets of ePCL. In order to examine the cellular alignment inside the 
ePCL scaffolds, two-layer scaffolds were cut in orthogonal planes to expose cross sections in x-z 
and y-z planes (Fig. 1). For the two-layer scaffold with aligned fibers arranged in orthogonal 
directions, the cross section exposing the x-z plane would cut “perpendicular” to aligned fibers in 
the upper layer (shown in blue in Fig. 1F) and “parallel” to aligned fibers in the lower layer 
(shown in green in Fig. 1F). Conversely, the cross section exposing the y-z plane would cut 
“parallel” to aligned fibers in the upper layer (shown in blue in Fig. 1F) and “perpendicular” to 
aligned fibers in the lower layer (shown in green in Fig. 1F). In contrast, the ePCL construct with 
two layers of randomly oriented fibers would appear similar in the x-z and y-z plane cross 
sections (Fig. 1H). 
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2.4.2 Scaffold characterization  
The difference between ePCL scaffolds with aligned or randomly oriented fibers was examined 
by SEM (Fig. 2A-D). Aligned ePCL scaffolds had individual fibers 1-5 µm in diameter and most 
fibers existed individually without crossover (Fig. 2C). Randomly oriented ePCL scaffolds had 
similar fiber size, with most fibers intertwined with each other (Fig. 2D). Analysis of the fibers 
showed that the coherency factor of aligned ePCL scaffolds was statistically higher (0.555±0.058 
vs. 0.060±0.030; p = 1.91e-04 < 0.01) than that of the randomly oriented ePCL scaffolds (Fig. 
2E). 
 
2.4.3 Quantification of in vitro cellular alignment (x-y plane) 
Following two weeks of culture in vitro, the difference in alignment of cells on the surface of 
aligned and randomly oriented ePCL scaffolds (x-y plane) was evaluated by the expression of α-
SMA (Fig. 2G,H) and GFP (Fig. 2J,K). Analysis of the coherency factor from immunostained 
images showed that cells cultured on aligned ePCL scaffolds were statistically more aligned (α-
SMA: 0.385±0.023 vs. 0.103±0.011; p = 4.36e-05 < 0.01, GFP: 0.309±0.013 vs. 0.079±0.013; p 
= 2.75e-05 < 0.01) than cells cultured on randomly oriented ePCL scaffolds for both markers 
(Fig. 2F,I). 
 
2.4.4 Quantification of infiltrating host cells’ alignment inside two-layer ePCL scaffolds (x-z and 
y-z planes) 
After two weeks of implantation, the alignment of infiltrating host cells into the two-layer ePCL 
scaffolds without seeded SMS was analyzed by immnuostaining for α-SMA and by HE (Fig. 
3,4). Host cell infiltration inside ePCL scaffolds with two layers of orthogonally aligned fibers 
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(Fig. 3) mimicked the cellular alignment of intestinal circular and longitudinal smooth muscle 
layers (Fig. 1C,D). The alignment of upper and lower layers was completely exchanged when the 
cross section was switched from the x-z to the y-z plane. The upper layer had “perpendicular” 
and lower layer had “parallel” alignment to the cross sections in x-z plane, while the upper layer 
had “parallel” and lower layer had “perpendicular” alignment to the cross sections in y-z plane 
(Fig. 3A-D). In contrast, the upper and lower layers in ePCL scaffolds with randomly oriented 
fibers demonstrated similar cellular alignment for both cross sections in the x-z and y-z planes 
(Fig. 4A-D). 
Coherency analysis of α-SMA expression for two-layer ePCL scaffolds with aligned 
fibers confirmed that cells in the lower layer were statistically more aligned (0.402±0.039 vs. 
0.191±0.045; p = 2.22e-05 < 0.01) than cells in the upper layer in x-z plane, while cells in the 
upper layer were statistically more aligned (0.424±0.039 vs. 0.212±0.055; p = 1.59e-05 < 0.01) 
than cells in the lower layer in y-z plane (Fig. 3E). The coherency distribution in the x-z plane 
showed that most of the cells in lower layer were more aligned than those in the upper layer with 
little overlap (Fig. 3F). 
In contrast, coherency analysis of α-SMA expression for two-layer ePCL scaffolds with 
randomly oriented fibers demonstrated no statistical difference in cellular alignment between 
upper and lower layers in both x-z plane cross sections (0.334±0.056 vs. 0.345±0.055; p = 
0.798 > 0.01) and y-z plane cross sections (0.355±0.014 vs. 0.313±0.023; p = 0.020 > 0.01) (Fig. 
4E). The coherency distribution in the x-z plane showed that most of the cells in upper and lower 
layers had similar cellular alignment, as demonstrated by the extensive overlap (Fig. 4F). 
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2.4.5 Quantification of cellular alignment inside SMS-seeded two-layer ePCL scaffolds (x-z and 
y-z planes) 
After three weeks of in vitro culture followed by 4 days of implantation, cellular alignment 
inside SMS-seeded two-layer ePCL scaffolds was analyzed by HE staining and immunostaining 
for α-SMA (Fig. 5,6) and GFP (Fig. 7,8). Since α-SMA and HE stained cells from both seeded 
SMS and host, GFP was used to examine the cellular alignment from seeded SMS.  
Similar to the infiltrating host cells, the alignment of GFP-positive cells in upper and lower 
layers in aligned ePCL scaffolds was completely reversed when the cross section was switched 
from the x-z to the y-z plane. The upper layer had “perpendicular” and lower layer had “parallel” 
alignment to the cross sections in x-z plane, while the upper layer had “parallel” and lower layer 
had “perpendicular” alignment to the cross sections in y-z plane (Fig. 5A-D, 7A-D). Conversely, 
GFP-positive cells in the upper and lower layers in ePCL scaffolds with randomly oriented fibers 
demonstrated similar cellular alignment for both cross sections in the x-z and y-z planes (Fig. 
6A-D, 8A-D). 
Coherency analysis of α-SMA and GFP expressions for aligned two-layer ePCL scaffolds 
again demonstrated that cells in the lower layer were statistically more aligned (α-SMA: 
0.416±0.032 vs. 0.238±0.040; p = 6.85e-06 < 0.01, GFP: 0.423±0.017 vs. 0.251±0.041; p = 
2.47e-03 < 0.01) than cells in the upper layer in x-z plane, while cells in the upper layer were 
statistically more aligned (α-SMA: 0.458±0.050 vs. 0.178±0.029; p = 6.85e-06 < 0.01, GFP: 
0.517±0.047 vs. 0.277±0.028; p = 1.60e-03 < 0.01) than cells in the lower layer in y-z plane (Fig. 
5E, 7E). The coherency distribution in x-z plane showed that most of the cells in lower layer 
were more aligned than those in the upper layer with little overlap (Fig. 5F, 7F). 
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In contrast, coherency analysis of α-SMA and GFP expressions for random two-layer 
ePCL scaffolds showed no statistical differences in cellular alignment between upper and lower 
layers in both x-z plane cross sections (α-SMA: 0.351±0.059 vs. 0.347±0.020; p = 0.909 > 0.01, 
GFP: 0.373±0.033 vs. 0.389±0.008; p = 0.461 > 0.01) and y-z plane cross sections (α-SMA: 
0.309±0.041 vs. 0.327±0.043; p = 0.565 > 0.01, GFP: 0.357±0.038 vs. 0.373±0.046; p = 0.664 > 
0.01) (Fig. 6E, 8E). The coherency distribution in x-z plane showed that most of the cells in 
upper and lower layers had similar cellular alignment with extensive overlap (Fig. 6F, 8F). 
 
2.4.6 Summary of cellular alignment inside two-layer ePCL scaffolds (x-z and y-z planes) 
For both x-z and y-z planes of two-layer ePCL scaffolds with orthogonally aligned fibers, the 
highest coherency factor was associated with cross sections that were cut “parallel” to aligned 
fibers (above 0.4), whereas the coherency factor was significantly lower when cross sections 
were taken “perpendicular” to aligned fibers (below 0.3). The layers of randomly aligned ePCL 
scaffolds consistently had average coherency factors that fell between 0.3 and 0.4 (Fig. 3-8E). In 
addition, the coherency distribution of x-z plane analysis displayed Gaussian distribution (Fig. 3-
8F). These results occurred for cells from both host and seeded SMS, thus validating that the 
fiber alignment of ePCL had influenced the cellular alignment inside two-layer scaffolds (Fig. 3-
8). 
 
2.5 DISCUSSION 
We demonstrated that orthogonally aligned ePCL scaffolds could induce cellular alignment 
similar to intestinal circular and longitudinal smooth muscle layers. In contrast, ePCL scaffolds 
with randomly oriented fibers did not produce such distinguishable cellular alignment. Cells 
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from both seeded SMS and host infiltrated into the entire depth of the two-layer ePCL scaffolds. 
These results suggested that cells tended to elongate along the fiber direction not only on the 
surface of ePCL, but also inside the ePCL after infiltration. 
While previous studies have shown 2D cellular alignment with oriented fibers (x-y plane) 
[2,5–9,22], our study has demonstrated that this approach is also applicable to 3D cellular 
alignment in vivo (x-z and y-z planes). We chose FDA-approved ePCL as scaffolds for clinically 
translatable practice. As a result, with only gelatin coating of the ePCL, cells from both seeded 
SMS and host aligned and elongated along the fiber directions inside the ePCL scaffolds. This 
system can be useful in tissue regeneration where alignment is essential: vasculature [2,3,27], 
myocardial tissue [4], musculoskeletal tissue [5], nervous system [6,7], and connective tissue 
[8,9].  
A prior study suggested that the loss of architecture due to rapid degradation of the 
scaffold prior to the completion of tissue remodeling could impair cellular alignment and cause 
scar formation [28]. However, ePCL in vivo degradation studies showed only 20-30% molecular 
weight reduction after 3-6 months, without structural deterioration [28–31]. Similarly, in our 
study, there was no significant degradation of the scaffold at explantation, and ePCL fibers could 
still been seen on histology. Whether the observed cellular alignment will persist after ePCL 
degradation is unclear. The cells may still maintain their orientation because the extracellular 
matrix that replaced the ePCL fibers may also be aligned [32].  Future studies are needed to 
evaluate the longevity of cellular alignment after degradation of the ePCL. 
Our ultimate goal is to construct fully functional intestinal smooth muscle layers capable 
of peristalsis. Future studies will use this system as a foundation to mimic the intestinal smooth 
muscle layers, by adding additional components into the two orthogonally aligned ePCL 
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scaffolds. For example, purified enteric neuronal cells and interstitial cells of Cajal can be seeded 
in-between the two-layer ePCL scaffolds to serve as the myenteric plexus and aid intestinal 
smooth muscle cells by providing the necessary signals for peristalsis. Intestinal constructs 
fabricated from this two-layer aligned ePCL may be used to generate full-thickness intestine 
useful for the treatment of short bowel syndrome or inflammatory bowel disease [33–36]. 
 
2.6 CONCLUSION 
Our study demonstrated that orthogonally aligned ePCL scaffolds can regenerate the cellular 
alignment of native intestinal circular and longitudinal smooth muscle layers. Our analysis 
quantitatively confirmed that cells align along the ePCL fibers not only on the surface (x-y 
plane) but also inside of the ePCL scaffolds (x-z & y-z planes). Future development of this 
system by adding myenteric plexus components will promote the creation of more functional 
intestinal smooth muscle layers. Similarly, this system can be applied to other types of tissues 
engineering that require alignment. Our investigation validated the significance of fiber 
alignment within scaffolds for engineering three dimensionally aligned tissues. 
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2.8 FIGURES 
 
Fig. 1. Schematic diagram of two-layer scaffolds for mimicking small intestine layers. (A) Basic setup for 
fabricating electrospun polypolycaprolactone (ePCL) sheets. (B) Laser cut ePCL scaffolds with aligned 
and random fibers. (C) Immunofluorescence of smooth muscle actin (α-SMA) expression and (D) HE 
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staining of adult, mouse small intestine in cross section. Preparation of two-layer ePCL scaffolds with (E) 
aligned or (G) randomly oriented fibers for implantation. In order to mimic the intestinal circular and 
longitudinal muscle layers, two-layer ePCL scaffolds with orthogonally oriented fibers were seeded with 
intestinal smooth muscles strips (SMS) and connected with a thin collagen gel before implantation. Two-
layer ePCL scaffolds with randomly oriented fibers were used as controls. To compare the cell alignment 
inside the ePCL, two-layer scaffolds with (F) aligned or (H) randomly oriented fibers were cut in two 
perpendicular planes to expose cross sections in x-z and y-z planes. Scale bar = 50 µm. L = Lumen. ⊗ = 
alignment perpendicular to the cross section. ↔ = alignment parallel to the cross section. 
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Fig. 2. Alignment of cells on SMS-seeded ePCL scaffolds. Scanning electron micrographs of ePCL with 
(A, C) aligned and (B, D) randomly oriented fibers at 250x and 1000x magnifications. (E) Coherency 
analysis of aligned and random ePCL (n=3). Scaffolds were seeded with SMS and immunostained at day 
14. Images were taken to show the cell alignment on the ePCL surface (x-y plane). (G, H) α-SMA and (J, 
K) green fluorescent protein (GFP) expression of SMS seeded on (G, J) aligned and (H, K) random ePCL. 
Coherency analysis of (F) α-SMA (n=3) and (I) GFP (n=3) expression of SMS seeded on aligned and 
random ePCL. *p < 0.01. Error bar = SD. Scale bar A, B, G, H, J, K = 200 µm; scale bar C, D = 50 µm. 
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Fig. 3. Quantification of α-SMA alignment expressed by infiltrating host cells inside two-layer ePCL 
scaffolds with aligned fibers. ePCL scaffolds were retrieved on day 14 after implantation. α-SMA 
expression of infiltrating host cells inside aligned ePCL scaffolds in the (A) x-z and (B) y-z planes. HE 
staining of infiltrating host cells inside aligned ePCL scaffolds on the (C) x-z and (D) y-z planes. (E) 
Coherency analysis and (F) the distribution (x-z plane as representative) of α-SMA alignment of 
infiltrating host cells inside two-layer aligned ePCL scaffolds (n=6). *p < 0.01. Error bar = SD. Scale bar 
= 100 µm. SM = Skeletal Muscle. ⊗ = alignment perpendicular to the cross section. ↔ = alignment 
parallel to the cross section. 
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Fig. 4. Quantification of α-SMA alignment of infiltrating host cells inside two-layer ePCL scaffolds with 
randomly oriented fibers. ePCL scaffolds were retrieved on day 14 after implantation. α-SMA expression 
of infiltrating host cells inside randomly oriented ePCL scaffolds on the (A) x-z and (B) y-z planes. HE 
staining of infiltrating host cells inside randomly oriented ePCL scaffolds on the (C) x-z and (D) y-z 
planes. (E) Coherency analysis and (F) the distribution (x-z plane as representative) of α-SMA alignment 
of infiltrating host cells inside two-layer random ePCL scaffolds (n=4). p > 0.01. Error bar = SD. Scale 
bar = 100 µm. SM = Skeletal Muscle. 
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Fig. 5. Quantification of α-SMA alignment of seeded SMS and infiltrating host cells inside two-layer 
ePCL scaffolds with aligned fibers. ePCL scaffolds were cultured in vitro for 3 weeks and retrieved on 
day 4 after implantation. α-SMA expression of seeded SMS and infiltrating host cells inside aligned ePCL 
scaffolds on the (A) x-z and (B) y-z planes. HE staining of seeded SMS and infiltrating host cells inside 
aligned ePCL scaffolds on the (C) x-z and (D) y-z planes. (E) Coherency analysis and (F) the distribution 
(x-z plane as representative) of α-SMA alignment of seeded SMS and infiltrating host cells inside two-
layer aligned ePCL scaffolds (n=6). *p < 0.01. Error bar = SD. Scale bar = 100 µm. SM = Skeletal 
Muscle. ⊗ = alignment perpendicular to the cross section. ↔ = alignment parallel to the cross section. 
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Fig. 6. Quantification of α-SMA alignment of seeded SMS and infiltrating host cells inside two-layer 
ePCL scaffolds with randomly oriented fibers. ePCL scaffolds were cultured in vitro for 3 weeks and 
retrieved on day 4 after implantation. α-SMA expression of seeded SMS and infiltrating host cells inside 
randomly oriented ePCL scaffolds on the (A) x-z and (B) y-z planes. HE staining of seeded SMS and 
infiltrating host cells inside randomly oriented ePCL scaffolds on the (C) x-z and (D) y-z planes. (E) 
Coherency analysis and (F) the distribution (x-z plane as representative) of α-SMA alignment of seeded 
SMS and infiltrating host cells inside two-layer random ePCL scaffolds (n=4). p > 0.01. Error bar = SD. 
Scale bar = 100 µm. SM = Skeletal Muscle. 
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Fig. 7. Quantification of GFP alignment of seeded SMS inside two-layer ePCL scaffolds with aligned 
fibers. ePCL scaffolds were cultured in vitro for 3 weeks and retrieved on day 4 after implantation. GFP 
expression of seeded SMS inside aligned ePCL scaffolds on the (A) x-z and (B) y-z planes. HE staining 
of seeded SMS inside aligned ePCL scaffolds on the (C) x-z and (D) y-z planes. (E) Coherency analysis 
and (F) the distribution (x-z plane as representative) of GFP alignment of seeded SMS inside two-layer 
aligned ePCL scaffolds (n=3). *p < 0.01. Error bar = SD. Scale bar = 100 µm. SM = Skeletal Muscle. 
Note: Fig. 5 and Fig. 7 are the same locations. ⊗ = alignment perpendicular to the cross section. ↔ = 
alignment parallel to the cross section. 
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Fig. 8. Quantification of GFP alignment of seeded SMS inside two-layer ePCL scaffolds with randomly 
oriented fibers. ePCL scaffolds were cultured in vitro for 3 weeks and retrieved on day 4 after 
implantation. GFP expression of seeded SMS inside randomly oriented ePCL scaffolds on the (A) x-z and 
(B) y-z planes. HE staining of seeded SMS inside randomly oriented ePCL scaffolds on the (C) x-z and 
(D) y-z planes. (E) Coherency analysis and (F) the distribution (x-z plane as representative) of GFP 
alignment of seeded SMS inside two-layer random ePCL scaffolds (n=3). p > 0.01. Error bar = SD. Scale 
bar = 100 µm. SM = Skeletal Muscle. Note: Fig. 6 and Fig. 8 are the same locations. 
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CHAPTER THREE: INTERSTITIAL CELLS OF CAJAL ENABLE ENGINEERING OF 
RHYTHMICALLY CONTRACTING INTESTINAL SMOOTH MUSCLE 
3.1 ABSTRACT 
Oriented smooth muscle layers in the intestine contract rhythmically due to the action of 
interstitial cells of Cajal (ICC) that serve as pacemakers of the intestine. Disruption of ICC 
networks has been reported in various intestinal motility disorders, which limit the quality and 
expectancy of life.  A significant challenge in intestinal smooth muscle engineering is the rapid 
loss of function in cultured ICC and smooth muscle cells (SMC). Here we demonstrate a novel 
approach to maintain the function of both ICC and SMC in vitro. Primary intestinal SMC 
mixtures cultured on feeder cells seeded electrospun poly(3-caprolactone) scaffolds exhibited  
rhythmic contractions with directionality for over 10 weeks in vitro. The simplicity of this 
system allows its wide usage in discovery research for motility disorders and tissue engineering. 
 
3.2 INTRODUCTION 
The intestine is responsible for digestion, nutrient and water absorption, and waste removal. An 
increasing number of people are suffering from various intestinal disorders which severely affect 
their life expectancy and quality of life1. According to the Crohn’s and Colitis Foundation of 
America, there are approximately 1.6 million Americans suffering from inflammatory bowel 
disease in 2014, which is a 0.2 million increase from 2008.  
When the intestine fails to function, current medical treatment options have significant 
limitations: total parenteral nutrition leads to unacceptably high morbidity and mortality rates 
and transplantation faces donor scarcity,  organ rejection, and life-long immunosuppression2. 
Therefore, engineering functional intestinal tissue raises hope as an alternative therapeutic 
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strategy for patients with intestinal failure. Previous studies have been done to regenerate the 
intestinal epithelium3 and many types of muscle, including vascular smooth muscle5,6, cardiac7–10 
and skeletal muscle5,11. However, few have investigated the regeneration of intestinal smooth 
muscle12,13. 
The aligned smooth muscle layers of the intestine move autonomously. Spontaneous 
electrical slow waves derived from pacemaker activity of the intestine arrange contractile 
patterns into phasic contractions that are the basis for peristalsis. Neural or hormonal inputs do 
not generate the intrinsic pacemaker activity of smooth muscles but affect the degree of coupling 
between pacemaker activity and contractions14. Interstitial cells of Cajal (ICC) are a specialized 
group of cells responsible for the pacemaker activity in visceral smooth muscles, generating and 
actively propagating the slow waves15,16. 
Isolated intestinal SMCs may generate fast Ca2+ action potentials, but not the 
spontaneous slow waves in smooth muscles. Conversely, isolated ICC generate spontaneous 
electrical rhythmicity similar to the electrical activity in intact smooth muscles17,18. The binding 
of stem cell factor (SCF) to the receptor tyrosine kinase Kit induces a signaling pathway in ICC, 
which is critical for the normal development of ICC and rhythmic activity19–23. SCF stimulation 
of Kit is essential for ICC maintenance 22,24, and Ca2+ activated Cl–  channels (Ano1) expressed 
on ICC were identified as the key conductance responsible for the pacemaker activity18. 
However, ICC comprise less than 10% of the cells within intestinal smooth muscle, and isolated 
ICC are difficult to maintain in cell culture. ICC tend to lose their characteristic morphologies 
and Kit immunoreactivity after enzymatic digestion during the cell isolation procedure. Although 
ICC can grow and develop networks that produce electrical rhythmicity in cell culture, those 
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dispersed ICC undergo extensive phenotypic changes within a few days, including the apparent 
loss of the ion channels responsible for the slow wave activity14,18,25,26.  
Using a feeder cell system, we demonstrate a novel protocol where both purified ICC and 
isolated intestinal smooth muscle cell (ISMC) mixtures can be cultured for weeks in vitro with 
intact pacemaker ability and rhythmic contractions. Disruption of ICC networks and the loss of 
SMC maturity in intestinal muscularis have been reported in a variety of diseases resulting in 
intestinal motility disorders leading to pseudo-obstruction, Hirschsprung’s disease, inflammatory 
bowel diseases, and slow transit constipation27–30. Therefore, this system provides not only 
crucial progress in intestinal smooth muscle engineering, but also an in vitro platform to 
investigate cellular phenotypes and mechanisms associated with different intestinal disorders, to 
screen drugs that may alter motility, and to identify the biomarkers for early diagnosis and 
clinical stratification.  
 
3.3 RESULTS 
3.3.1 ICC proliferation in vitro 
To enrich the ICC population in culture, immunomagnetic sorting was performed on primary 
intestinal smooth muscle cell mixture (ISMC Mix, derived from C57BL/6 mouse) that were first 
cultured on gelatin for 3 days. The resultant MACS+ cells (MACS purified ICC population using 
antibody to Kit) proliferated on mitomycin-treated STO cells that expressed stem cell factor 
(SCF). The MACS+ cells exhibited ICC morphology and expressed Kit and Ano1 for up to two 
weeks in culture (Fig. 1a-b). When a 60k per well cell seeding density was used, MACS+ cells 
spread on STO cells in 48-well plates and became confluent in one week. A lower seeding 
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density was tested to achieve more cell expansion. MACS+ cells with seeding density of 15k 
proliferated on STO cells and formed a confluent layer in two week (Fig. 1a-b).  
STO cells are embryonic fibroblasts commonly used for embryonic stem cell culture. 
Embryonic fibroblasts derived from the same mouse strain as ISMC Mix (C57BL/6), MEF, were 
also tested with MACS+ cell culture, with gelatin-coated wells serving as controls. STO cells 
supported MACS+ cell growth better than gelatin coating and MEF cells (Fig. 1c-e). Although 
MACS+ cells proliferated on all three conditions (Fig. 1d), cells maintained the ICC marker Kit 
significantly better on STO cells than on MEF or gelatin (Fig. 1c, 1e and Supplementary Fig. 
1). Although with the same 100k cell seeding density, more STO cells than MEF were attached 
because the size of STO cells is smaller than MEF (Supplementary Fig. 2a, c).  STO cells 
expressed significantly higher kitl mRNA level at day 0 and after 7 days in culture, and STO 
cells expressed more SCF protein at day 7 than MEF cells. The difference in SCF expression 
may be responsible for the difference in ICC survival (Supplementary Fig. 2b, d, e). This is 
further supported by varying STO cell density, which demonstrated a density-dependent 
proliferation of MACS+ cells31 (Fig.1f). 
Exogenously added SCF, however, was insufficient to support ICC survival. 
Concentrations up to 100ng/ml of free SCF added to the culture medium failed to preserve ICC 
phenotype (Fig. 1g). There may be additional factors secreted by STO cells that are beneficial 
for ICC growth. When STO conditioned media (CM) was mixed into the culture medium (1:1 
ratio) for MACS+ cell culture, CM provided a cell density dependent benefit to MACS+ cells. 
CM provided significant improvement in MACS+ cell growth on gelatin only at a lower seeding 
density compared to control (Fig. 1h). Providing CM to a low seeding density, MAC+ cells 
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expressed Kit to a level comparable to MACS+ cells seeded at higher density without CM (Fig. 
1h).  
The cultured MACS+ cells were passaged by performing an additional sorting on 
MACS+ cells growing on STO cells. Such passaged MACS+ cells (P-MACS+ cells) were 
seeded again on STO cells. Although the growth rate was slower, P-MACS+ cells also 
proliferated on STO cells and exhibited ICC morphology and expressed Kit and Ano1 (Fig. 2a-
c).  
 
3.3.2 Rhythmic pacemaker activity of cultured ICC (MACS+ and P-MACS+ cells) 
To determine whether cells cocultured with STO cells were functional, we examined the 
intracellular Ca2+ oscillation frequency in MACS+ and P-MACS+ cells cultured on STO cells or 
gelatin at different density. With a higher seeding density, the MACS+ cells on STO cells 
exhibited a rhythmic Ca2+ oscillation frequency that was significantly higher than MACS+ cells 
cultured on gelatin (Fig. 2d). STO cells also supported P-MACS+ cells seeded at a higher 
density, and these cells exhibited a rhythmic Ca2+ oscillation frequency similar to MACS+ cells 
before passaging (Fig. 2e). Moreover, it’s easier to maintain and restore the functionality of 
MACS+ cells seeded at a higher density. With a lower seeding density, it was still possible to 
recover the functionality of MACS+ cells, but it took a longer culture time and resulted in 
slightly slower frequency (Fig. 2e). The number of functional cells in P-MACS+ culture was 
about half of that in MACS+ culture due to a slower growth rate (Fig. 2a-c). A higher seeding 
density and lower passage number were beneficial for cells to form a network sooner, which lead 
to an earlier establishment of coordinated pacemaker activity in culture (Fig. 2e). Moreover, 
MACS+ cells cultured on STO cells demonstrated stable, periodic Ca2+ oscillation over time 
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(Fig. 2f and Supplementary Video 1). Our results suggest that the STO culture system 
facilitates proliferation of not only MACS+ cells but also P-MACS+ cells over time while 
preserving their pacemaker activities. 
 
3.3.3 Application of MACS+ cells cultured on STO cells 
ICC residing in the intestinal smooth muscle tend to align along the smooth muscle orientation32–
35 (Supplementary Fig. 3a). In order to induce the proper alignment, MACS+ cells were 
cultured on STO-seeded electrospun poly(3-caprolactone) (ePCL) scaffolds32 (Supplementary 
Fig. 3b). MACS+ cells proliferated and aligned along the ePCL fiber orientation after 2 weeks 
(Fig. 3a). Coherency analysis of Kit expression confirmed that MACS+ cells cultured on ePCL 
scaffolds (aligned) were statistically more aligned than those cultured on glass (random 
orientation) controls (Fig. 3b,c). Further, we demonstrated that MACS+ cells (GFP+) survived 
for at least a week in vivo, following colonoscopic injection into the rectal submucosa of 
C57BL/6 mice. Injected MACS+ cells, identified by GFP, co-localized with Ano1 expressed by 
ICC but not with α-SMA (Fig. 3d,e). Moreover, MACS+ cells were distributed around the 
injection site of the submucosa as indicated by carbon ink and demonstrated alignment along the 
smooth muscle layer, accompanied by native ICC and SMCs (Fig. 3d,e). These results 
demonstrate that the in vitro expanded ICC not only can be align by using scaffolds but also can 
survive in vivo through colonoscopic injections. 
 
3.3.4 ISMC Mix maintenance on STO cells 
To test whether our approach of culturing MACS+ cells with spontaneous Ca2+ oscillation could 
support periodic contractions of SMCs, ISMC Mix was cultured on STO cells for three weeks. 
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At day 7, ISMC Mix cultured on STO cells in F12 medium expressed the highest level of ICC 
markers (Kit and Ano1 co-localization), SMCs marker (MHC) and neuronal marker (β-tubulin), 
followed by ISMC Mix cultured on STO cells in FBS medium and ISMC Mix cultured on 
gelatin in FBS medium (Fig. 4a). Comparable to the trends observed in immunostaining, ISMC 
Mix on STO cells cultured in F12 medium showed the greatest expression of Kit, Myh11, Tubb3, 
Kitl, and Acta2 up to three weeks, with the exception that cells cultured on STO cells in FBS 
medium had a slightly higher expression of Kitl at weeks two and three (Fig. 4b). Cells cultured 
on STO cells had higher expression of Kit and Kitl (STO-FBS vs. Ge-FBS) while F12 medium 
induced higher expression of Myh11, Tubb3, and Acta2 (STO-F12 vs. STO-FBS) (Fig. 4b). 
Cultures with STO cells and F12 medium demonstrated the greatest expression of Myh11 over 
time (Fig. 4b). ISMC Mix cultured on gelatin had a higher proliferation but lower expression of 
other markers compared to ISMC Mix cultured on STO cells with FBS or F12 medium (Fig. 4b). 
As predicted from the immunostaining and mRNA expression, ISMC Mix cultured on STO cells 
demonstrated periodic contractions (Fig. 4c) while cells cultured on gelatin in FBS medium did 
not contract (not shown). STO cells with F12 medium enabled ISMC Mix to retain faster 
frequency over a longer period of time compared to ISMC Mix cultured on STO cells in FBS 
medium (Fig. 4c). STO cells were shown to be effective in maintaining not only functional ICC 
but also functional ISMC. Overall, these results suggest that STO cells with F12 medium is the 
optimal condition to culture ISMC Mix with periodic contractions (Supplementary Videos 2,3).  
 
3.3.5 Engineering functional intestinal smooth muscle 
To create an implantable tissue construct for regenerative medicine, we engineered intestinal 
smooth muscle with proper alignment and functionality by culturing ISMC Mix on STO-seeded 
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ePCL in F12 medium. ISMC Mix cultured on STO-seeded ePCL demonstrated unceasing, 
rhythmic contraction over 10 weeks in vitro (Fig. 5f). After 10 weeks of culture, the constructs 
were examined with immunostaining and qPCR, demonstrating expression of ICC, SMC and 
neuronal markers (Fig. 5a,b). Although STO cells played essential roles in supporting ISMC 
Mix culture, the effect of STO cells likely declined over time due to its mitomycin C treatment. 
When STO cells were seeded alone, the reduction in the cell number and viability were observed 
over time (Supplementary Fig. 4). 
 To quantify the intensity and directionality of the periodic contractions generated by 
ISMC Mix on ePCL scaffolds, the dimensions of the most contracted scaffold was compared to 
those in the most relaxed scaffold. The change in area of the scaffold (Fig. 5d) was mainly due to 
a significant change in the length of the scaffold along the direction of the fibers, labelled as the 
height of the ePCL scaffold (Fig. 5e). Moreover, the cells cultured on ePCL scaffolds showed 
surface alignment along the direction of the fibers in the scaffold (Fig. 5a,c). The alignment of 
ISMC Mix inside the ePCL scaffolds was also quantified as we had previously described32. 
Briefly, ePCL scaffolds were cut in two orthogonal planes to expose cross section parallel or 
perpendicular to ePCL’s aligned fibers. Coherency analysis (MHC, GFP and β-tubulin) and 
circularity analysis (DAPI) were used to compare the alignment in the two cross sections, where 
coherency factor ranges from 0 (perfect random) to 1 (perfect alignment) indicating cell 
alignment while circularity factor ranges from 0 (most elongated shape) to 1 (perfect circle) 
indicating elongation of nuclei due to cell alignment. Our results showed that the ISMC Mix 
cells infiltrated inside the ePCL and arranged along the ePCL’s aligned fibers (Supplementary 
Fig. 5). Culturing ISMC Mix on STO-seeded ePCL produced intestinal smooth muscle 
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constructs with proper alignment and spontaneous rhythmic contractions (Supplementary Video 
4). 
 
3.3.6 ICC is essential for rhythmic contraction of ISMC Mix 
To confirm the role of ICC in ISMC Mix in producing spontaneous, rhythmic contractions, 
MACS+ cells were separated from ISMC Mix to create a MACS- cells population that contains 
few ICC. The MACS- cells were cultured on STO cells for 3 weeks in vitro, and its motility, 
gene and protein expression were analyzed. The comparison between passaged ISMC Mix 
(MACS0) and MACS- cells showed that the ICC population in MACS0 is essential for 
spontaneous rhythmic contractions (Fig. 6a-c). MACS- cells, without an ICC population, failed 
to exhibit rhythmic contractions even though SMCs and neuronal cells were present. We also 
performed a rescue experiment where MACS+ cells were added back to MACS- cells 5 days 
after they were cultured on STO cells (MACS-/+).The added MACS+ cells restored the rhythmic 
contractions of the MACS- cells cultured on STO cells in 5 weeks (Fig. 6d-f). This experiment 
confirms that ICC play an essential role in producing the spontaneous rhythmic contractions of 
cultured ISMC. 
 
3.4 DISCUSSION 
This study demonstrates that STO cells can support ICC in culture and maintains the 
spontaneous intracellular Ca2+ oscillation frequency within the previously published 
range16,18,26,36–41. These functional ICC pace the rhythmic contractions of SMC. It is also 
necessary for SMC to retain its maturity and express MHC to contract12,13 upon receiving 
pacemaker signals from functional ICC. The loss of maturity and functionality of either ICC or 
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SMC in culture is a major challenge for intestinal smooth muscle engineering12,13,42. Our system 
described here is the first approaches to achieving this goal by maintaining the functionality of 
both ICC and SMC, as well as neuronal cells cultured in vitro.  
This system provides an easily accessible in vitro model to investigate the molecular 
mechanisms underlying a functional smooth muscle. The combination of STO cells and F12 
medium works well to produce the in vitro culture of the intestinal smooth muscle. While it is 
likely that STO cells provide signals including preferable forms of SCF 43,44 and other factors31 
important for ICC to survive and function, the exact mechanisms that underlie these observations 
will need to be investigated further. The beneficial effects provided by STO cells are important 
during the initial phase of the smooth muscle cell culture. It is likely that other cell types within 
ISMC Mix eventually take over the function of STO cells due to the mitomycin C treatment. 
This novel culture method is likely to have broad applications. We demonstrated that 
both MACS+ cells and ISMC Mix were able to attach and align along ePCL scaffolds and that 
MACS+ cells cultured using our system survived in vivo after colonoscopic injections. 
Specifically, colonoscopic injections of ICC may help  motility disorders including diabetic 
gastroparesis,  pseudo-obstruction and Hirschsprung’s disease due to frequent defects in ICC 
networks reported in those disorders29,30. The culture method could also be applied to cells from 
other visceral organs45, and the cultured cells could be seeded on other biomaterials, used in 
other in vivo studies, and incorporated into microfluidic systems. 
Finally, this culture system is simple and reproducible for generating a functional smooth 
muscle layer in vitro. Our STO cell system only requires standard culture medium without 
specialized additives. STO cells are readily available at a low cost from commercial vendors. We 
believe that the STO cell system has the potential to become a common method to create 
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functional smooth muscle in vitro. This system may serve as the platform for both basic and 
applied research in intestinal motility. 
 
3.5 METHODS  
3.5.1 Electrospinning. 11% (w/w) solution of PCL (Durect Lactel, Birmingham, AL) was made 
in hexafluoro-2-propanol (Acros Organics, Thermo Fisher Scientific, Waltham, MA). The 
solution was kept on a shaker overnight to obtain a homogenous polymer solution. The mandrel 
was wrapped with aluminum foil to ease the removal of the scaffold. The PCL solution was 
transferred to a plastic syringe fitted with an 18-gauge needle, and secured onto a syringe pump 
(Harvard Apparatus, Holliston, MA). The solution was infused at 2.5 ml/h onto a rotating 
mandrel collector with an outer diameter of 32 mm that was positioned 12-15 cm away from the 
needle tip. The electrical potential difference between the needle (i.e., polymer solution) and the 
grounded mandrel collector was produced by a high voltage power supply (Glassman High 
Voltage, High Bridge, NJ). Scaffolds comprised of aligned ePCL fibers were fabricated using a 
mandrel rotational speed of 3450 rpm and an applied voltage of 15 kV. Less-aligned, “random” 
ePCL fibers were produced using a mandrel rotational speed of 1725 rpm and applied voltage of 
25 kV. After 0.5 ml of polymer solution had been dispensed from the syringe onto the rotating 
mandrel, the ePCL was carefully removed from the aluminum foil. Scaffolds were air-dried 
before laser cutting. 
 
3.5.2 Laser cutting. ePCL scaffolds were constructed as fiber sheets with dimensions 
approximately 10 x 2.5 cm and thickness of 100-150 µm, based on the mandrel used. These fiber 
sheets were cut into rectangular 8 x 6.5 mm scaffolds using the VERSA LASER CUTTER 2.3 
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(Universal Laser Systems, Scottsdale, AZ) with vector mode, 5% power, 100x speed, and 1000 
pulses/inch. Scaffolds were obtained by setting the longer edge of the rectangle to be along the 
fiber direction. The scaffolds were cleaned with air plasma (Harrick Plasma, Ithaca, NY) at 500 
mTorr, high power for 1 min and subsequently sterilized with strong UV (Dymax) for 1min. The 
scaffolds were washed once with phosphate buffered saline (PBS) (Invitrogen, Carlsbad, CA) 
before and after coating with gelatin solution (attachment factor solution (AF); Invitrogen) at 
37°C for at least 30 min. (Note: To improve the cell seeding onto ePCL scaffolds, PDMS molds 
with a well size the same as an ePCL scaffold were manufactured. This will allow ePCL scaffold 
to fit perfectly and stay at bottom of the PDMS well so that seeded cells attached effectively on 
the ePCL scaffold with minimal spillage to the bottom of the well). 
 
3.5.3 Scanning Electron Microscopy (SEM). The surface morphology of ePCL scaffolds with 
aligned or random fibers was assessed using a Nova NanoSEM 230 (FEI, Hillsboro, Oregon). 
The scaffolds without conductive coating were mounted on the sticky conductive carbon tape 
(Ted Pella, Redding, California ) on the top of aluminum stubs (Ted Pella, Redding, California) 
and examined under SEM with an accelerating voltage of 10 kV at low vacuum mode. 
 
3.5.4 Ethics statement. Animal usage complied with regulations set by the University of 
California, Los Angeles, Chancellor’s Animal Research Committee and was approved as animal 
protocol number 2005-169. All efforts were made to minimize pain and suffering. Two mice 
strains were used for these experiments: C57BL/6-Tg(Actb-EGFP)1Osb/J (“GFP”) (The Jackson 
Laboratory, Bar Harbor, ME) and wild type C57BL/6 (Charles River, Wilmington, MA). 
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3.5.5 Feeder cells preparation. Embryonic fibroblasts, STO (SIM, Santos Inbred Mouse) and 
MEF (C57BL/6) (both from ATCC) were expanded in STO medium (low glucose DMEM with 
GlutaMAXTM supplemented with 10% FBS and 1x ABAM (All Invitrogen)) and suspended in 
STO medium with 10% DMSO for cryopreservation (~106 cells/ml, 1ml/vial). ~106 feeder cells 
were thawed and cultured in gelatin coated T25 flasks with STO medium for a few days until 
confluency and treated with mitomycin C (Sigma). ~100k cells were seeded onto gelatin-coated 
substrates such as 48-well plate (Coring Costar, Fisher Scientific), eight-chamber slide (Nunc™ 
Lab-Tek™ II; Thermo Scientific) and ePCL scaffold, and cultured at 37°C with STO medium in 
a 10% CO2 incubator. Prepared feeder cells were used within 3 days. 
 
3.5.6 Primary intestinal smooth muscle cell mixture (ISMC Mix) isolation and culture. 
ISMC Mix were isolated from 7 to 10-day-old C57BL/6 neonates using previously described 
methods 12,32,36,46. The intestines were removed via a midline incision, and smooth muscle strips, 
containing both longitudinal and circular muscle layers, were gently teased from the intestines 
using fine forceps and placed in Hank’s Balanced Salt Solution (HBSS) without calcium and 
magnesium (Invitrogen, Carlsbad, CA) with 1x antibiotic-antimycotic (ABAM) (Invitrogen) on 
ice. Then the smooth muscle strips were minced and incubated at 37°C for 30~40 min in an 
enzyme solution containing collagenase (1.3 mg/ml Worthington Type II; Worthington 
Biochemical, Freehold, NJ), bovine serum albumin (BSA) (2 mg/ml), trypsin inhibitor (2 
mg/ml), ATP (0.27 mg/ml) (all from Sigma, St. Louis, MO), and 10% HBSS with calcium and 
magnesium (Invitrogen) in HBSS without calcium and magnesium containing 1x ABAM. The 
tissue was washed twice with vigorous pipetting with 10% FBS in HBSS without calcium and 
magnesium containing 1x ABAM. As a preparation for immunomagnetic sorting (MACS), the 
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resulting ISMC Mix was cultured in gelatin coated T25 flasks (ISMC Mix from ~4 pups in one 
T25 flask) for 3 days. Alternatively, 100k ISMC Mix were seeded onto substrates (48 well plate, 
eight-chamber slide, ePCL scaffold) with STO cells or gelatin coating. ISMC Mix were cultured 
at 37°C in a 5% CO2 incubator in FBS medium (Knockout™ D-MEM supplemented with 15% 
ECS-qualified FBS, 0.1 mM MEM Non-Essential Amino Acids solution, 2 mM L-glutamine, 0.1 
mM 2-mercaptoethanol, 1x ABAM, and 10mM HEPES (Invitrogen)). All ISMC Mix were 
cultured in FBS medium for the first 4 days followed by FBS or F12 medium (Advanced 
DMEM/F-12 supplemented with 2 mM L-glutamine, 1x ABAM, and 10mM HEPES 
(Invitrogen)). For conditioned medium (CM) preparation, STO medium was replaced with FBS 
medium after the STO cells formed a confluent monolayer and treated with mitomycin C. The 
FBS medium was collected after 4~5 days of incubation, passed through a 0.2 μm pore size filter 
(Pall Corporation, Port Washington, NY), and mixed with fresh FBS medium (1:1 ratio) as CM. 
The medium was changed every 2~3 days.  
 
3.5.7 Enrichment of ICC by immunomagnetic sorting (MACS).  After 3 days in culture, 
ISMC Mix were washed in PBS and incubated with 0.05% trypsin-EDTA (Invitrogen) at 37C for 
~2 min The ICC marker, Kit, the epitope recognized by ACK2, is easily altered or masked 
during the enzymatic digestion process. Therefore, it is important to avoid over-digestion. The 
reaction was stopped by adding FBS medium. The dissociated cells were washed once with 
sorting buffer (1% BSA (Fisher Scientific) and 2mM EDTA (Sigma) in PBS; ~pH7.2) and 
passed through a 100 µm cell strainer (Fisher Scientific). After centrifuging the cell suspension 
at 1000 rpm for 5 min, supernatant was aspirated completely. The cell pellet was re-suspended in 
sorting buffer and then well-mixed with the CD117 MicroBeads solution (Miltenyi Biotec, 
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Germany; 1:5 in sorting buffer). The cell suspension was incubated for 15 minutes at 4°C. For 
cells from four pups, 160 µL of sorting buffer and 40 µL of CD117 MicroBeads solution were 
used. Half the volume was used for cells isolated from two pups. The cell suspension was mixed 
with pipetting every 5 min. After being washed twice with the sorting buffer, the labeled cells 
were re-suspended in sorting buffer and 0.5 ml of the cell suspension was passed through pre-
wetted MS magnetic columns placed in a strong magnet (MiniMACS; Miltenyi Biotec) at a time. 
Cells from four pups were re-suspended in 4 ml sorting buffer and passed through two MS 
columns, 2 ml per each. After passing all of the cell suspension, MS columns were washed once 
with 1 ml of sorting buffer. Unlabeled cells were collected as flow-through (MACS- cells), while 
labeled cells retained in the columns were flushed out with 1 ml of sorting buffer after removing 
the column from the magnet (MACS+ cells). MACS+ cells were seeded onto gelatin or feeder 
cells and cultured at 37°C, 10% CO2 incubator in FBS medium.   
For P-MACS culture, the resultant MACS+ cells from 4 pups were all cultured on a 
STO-seeded well of a 6-well plate for 7 days, passaged with MACS, and subsequently cultured 
on STO cells in FBS medium. The medium was changed every 2~3 days. 
For MACS0, MACS- and MACS-/+ culture, CD117 MicroBeads labeled cells without 
passing through the MS magnetic column (MACS0) and MACS- cells were cultured on STO 
cells in FBS medium for 4 days followed by F12 medium. We also added MACS+ cells back to 
MACS- cell culture 5 days after they were cultured on STO cells in order to recover its 
spontaneous contractility (MACS-/+). The MACS-/+ cells were cultured in FBS medium for 7 
days, followed by F12 medium (2 days after adding the MACS+ cells onto MACS- cells). The 
medium was changed every 2~3 days. 
 
57 
 
3.5.8 Measurement of pacemaker activity in purified ICC (MACS+ cells). To monitor 
oscillations in intracellular Ca2+ concentration, cultured ICC (MACS+ cells) were incubated with 
1 part of 2X Fluo-4 Direct™ calcium reagent loading solution without probenecid (Invitrogen) 
and 1 part of FBS medium at 37°C, 5% CO2 incubator for 0.5~1 hour. Incubating for too short of 
a time will result in a weak signal while too long will result in an increased number of floating 
dead cells. Fluorescent images (680x512 pixels) were acquired with an Olympus IX71 
microscope using cellSens software (Olympus, Center Valley, PA) (acquisition rate: 4.8~7.7Hz; 
excitation wavelength: 494 nm; emission wavelength: 516 nm), and analyzed using custom 
MATLAB programs12 (region of interest analysis, Supplementary Fig. 6; fast-forward and gray 
scale normalization, Supplementary Fig. 7 ). In order to keep the temperature close to 37°C47,48, 
cells were limited to 5 min at room temperature for image acquisition and were returned to the 
incubator before repeating the process. 
 
3.5.9 Colonoscopic injection of MACS+ cells cultured on STO cells. Eight to 12 week old 
male and female C57BL/6J mice (n=3) were placed on water only diet overnight. Anesthesia was 
induced with 3% isoflurane then decreased to 1% for maintenance. Colonoscopy was performed 
by introducing a lubricated 1.9 mm endoscope (Karl Storz, Tuttlingen, Germany) into the mouse 
rectum, as previously described49. GFP+ MACS+ cells were cultured on STO cells for 4 days 
and MACS purified prior to the colonoscopic injection. The resulting P-MACS+ cells were re-
suspended in low glucose DMEM with GlutaMAXTM (Invitrogen) to a concentration of 5x105 
cells/ml and mixed with 1.5% permanent carbon ink (Spot; GI Supply, Camp Hill, PA) for later 
identification of the injection sites.  Using a 30 gauge custom-made needle fitted with pulled and 
beveled capillary tubing49, 100 µL of the cell suspension was injected into the submucosa of the 
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ventral rectum (n= 12 total). Mice were monitored for appropriate recovery from anesthesia and 
placed back in standard laboratory mouse cages with full access to water and chow. All mice 
were sacrificed 7 days after the cell injection procedure and colon specimens were isolated. 
 
3.5.10 Histology & immunofluorescence staining. Samples, including cell-seeded ePCL and P-
MACS+ injected intestine, were formalin-fixed and processed for paraffin embedding. Serial 5 
µm sections were cut and adhered to glass slides. Unstained slides were prepared for 
immunofluorescence staining. Slides were de-waxed with xylene and rehydrated with serial 
dilutions of ethanol. Next, slides were incubated in a citric buffer (Biogenex, San Ramon, CA) 
for 15 min at 95-100°C and allowed to cool for 15 minutes in an over flowing water bath. In 
vitro cultures and native smooth muscle strips were fixed without histologic processing. For Kit 
and Ano1 staining, samples were fixed with acetone for 30 min at 4°C. For all the other staining, 
samples were fixed with 10% formalin for 30 min at room temperature. After three washes with 
PBS, samples were treated with a blocking buffer containing 5% normal goat serum (Vector 
Labs, Burlingame, CA), 0.1% Triton X-100 (Sigma) in PBS for 1 hour at 4°C. Samples were 
then incubated with the following primary antibodies: Kit (1:500; eBioscience: 16-1172-82), 
Ano1 (1:500; Abcam: ab53212), MHC (1:100; Abcam: ab53219), β-tubulin (1:500; Abcam: 
ab78078), GFP (1:500; Aves: GFP-1020), and SCF (1:500; ab64677) diluted in staining buffer 
containing 5% normal goat serum in PBS overnight at 4°C. After two washes in PBS, samples 
were incubated in the dark with their corresponding Alexa Fluor® secondary antibodies (1:500; 
Invitrogen) and Alexa Fluor® 594 Palloidin (1:100; Invitrogen)  diluted in staining buffer for 
2~3 hours at room temperature. After three washes with PBS, Prolong Gold with DAPI 
(Invitrogen) was applied to each section and the slides were covered with glass coverslips. The 
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slides were allowed to cure at 4°C before storing at -80°C. Fluorescent images were acquired 
with an Olympus IX71 microscope with cellSens software (Olympus, Center Valley, PA) or 
confocal laser microscopy (TCS SP2 AOBS, TCS SP2 MP AOBS; Leica). 
 
3.5.11 DNA/RNA extraction and qPCR. DNA and RNA were extracted and purified from in 
vitro cultures using the DNeasy and RNeasy kits (Qiagen, Valencia, CA), respectively following 
the manufacture’s protocol. RNA samples were cleaned with RNase-Free DNase set (Qiagen) 
during the procedure. The qPCR reactions were prepared using a PCR master mix and the 
Quantitect Probe RT-PCR Kit (Qiagen) and performed on an ABI 7500 Real Time PCR System 
(Applied Biosystems). The primers and probe for gfp-DNA and Kit-RNA were custom- designed 
and purchased from Eurofins MWG Operon, (Huntsville, AL) : gfp-fw, 5’-
ACTACAACAGCCACAACGTCTATATCA-3’; gfp-rev, 5’-GGCGGATCTTGAAGTTCACC-
3’; gfp-pb, and 5’-[6-FAM]CCGACAAGCAGAAGAACGGCATCA[TAMRA-Q]-3’;  Kit-fw, 
5’-CCGTGAACTCCATGTGGCTAAAGA; Kit-rev, 5’-GGTGCCAGCTATTGTGCTTTACCT-
3’; Kit-pb, 5’-[6-FAM]TGAACCCTCAGCCTCAGCACATAGC[TAMRA-Q]-3’. All the other 
primer/probe mixtures were purchased from Applied Biosystems: Myh11 (Mm00443013_m1), 
Tubb3 (Mm00727586_s1), Kitl (Mm00442972_m1), Acta2 (Mm01546133_m1), Ano1 
(Mm00724407_m1) and Gapdh (Mm99999915_g1). DNA qPCR results were analyzed using a 
standard prepared with known number cells from ISMC Mix. RNA qPCR results were analyzed 
using Gapdh as the housekeeping gene and de-epithelialized intestine as reference. 
 
3.5.12 MTS assay.  MTS assay was conducted to test the viability of mitomycin C treated STO 
cells over time. 100k mitomycin C treated STO cells were seeded on to 48-well plate in STO 
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medium overnight, followed by the same series of medium as the preparation for ISMC Mix 
feeder layer. At each time point, wells with cells and without cells (control) were incubated with 
a mixture of CellTiter 96® AQueous One Solution Reagent (Promega) in appropriate medium 
(1:5 volume ratio) at 37°C in a 5% CO2 incubator for an hour. The absorbance was measured at 
490 nm (SynergyTM HT; BioTek). Data were normalized to controls. 
 
3.5.13 Data Analysis. The frequency of spontaneous contractions of the cells was analyzed 
manually from recorded videos (680x512 pixels; acquisition rate: 5.0 Hz) acquired with an 
Olympus IX71 microscope using cellSens software (Olympus, Center Valley, PA). The area, 
height and width of the most contracted ePCL scaffolds were normalized to that of the most 
relaxed ePCL scaffolds with ImageJ using images extracted from a representative video and 
manually outlined ePCL scaffolds. In order to compare the size of feeder cells, area of MEF was 
normalized to that of STO cells with ImageJ. For the cell alignment quantification, ImageJ was 
used to conduct circularity analysis (DAPI) and the plugin OrientationJ was used to conduct 
coherency analysis (Kit, MHC, GFP and β-tubulin). 
 
3.5.14 Statistical Analysis. One-way ANOVA followed by Tukey test or two-tailed unpaired 
Student’s t-test was used depending on the number of simultaneous conditions to analyze. Levels 
of significance were set at *** P < 0.0001, ** P < 0.01, and * P < 0.05. Data were expressed as 
the mean ± the standard deviation (s.d.). n indicates the number of independent experiments 
(different primary cell isolations from different animals) except for the following cases: Fig. 2de, 
n = number of cell cultures (from 3 different independent experiments); Fig. 3c, n = number of 
images (from one independent experiment); Fig. 4c, n = number of videos (from two 
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independent experiments); Fig. 5de, n = number of images (extracted from a representative 
video). 
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3.7 FIGURES 
 
Figure 1 | Maintenance of MACS+ cells cultured on STO cells. (a) Confocal images of ICC markers, Kit 
(red), Ano1 (green), and co-localization (yellow). 60k MACS+ and 15k MACS+ cells were cultured for 7 
days and 14 days respectively. Scale bar, 100 µm. (b) MACS+ cells were analyzed for Kit mRNA 
expression (b-d: day 1, 4, 7 n=4; day 14 n =2). (c-d) GFP+ MACS+ cells were seeded on STO cells, 
MEF, and Ge, cultured, and analyzed for mRNA expression of Kit (c) and gfp DNA (d). STO cells and 
MEF do not express Kit/gfp. (e)  mRNA expression of Kit for MACS+ cells cultured on STO cells, MEF 
and Ge for 7 days. (f) mRNA expression of Kit for MACS+ cells cultured on different STO seeding 
densities for 7 days, where 100% is 100k (100%,  n=5; 50%,  n=4; 25%,  n=2). (g) mRNA expression of 
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Kit for MACS+ cells cultured on Ge for 7 days in media supplemented with 25, 50, or 100 ng/ml of 
soluble scf (n=2). STO and Ge were controls (n = 5). (h) mRNA expression of Kit for 60k or 15k 
MACS+ cells cultured on Ge for 7 days supplemented with conditioned media from STO (Ge-CM), 
where Ge was the control (n= 4). STO = Mouse Embryonic Fibroblast (Santos Inbred Mouse, SIM). MEF 
= Mouse Embryonic Fibroblast (C57BL/6).  Ge = gelatin coating. Feeder cells (STO, MEF) were 
mitomycin C treated. *Samples were normalized to de-epithelialized intestine. Error bars, s.d. *** P < 
0.0001, * P < 0.05. 
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Figure 2 | Maintenance of passaged MACS+ cells on STO cells and rhythmic pacemaker activity of 
cultured ICC (MACS+ and passaged MACS+ cells). 60k sorted cells were cultured for 7 days unless 
otherwise noted. (a) Immunofluorescence of passaged MACS+ (P-MACS+) cells with ICC markers, Kit 
(red) and Ano1 (green) and with co-localization (yellow). MACS+ cells were cultured on STO cells for 7 
days and were passaged and sorted with MACS (P-MACS+). P-MACS+ cells were subsequently cultured 
on STO cells. Scale bar, 200 µm. (b-c) Growth comparison of GFP+ MACS+ and P-MACS+ cells with 
mRNA expression of Kit (b) and DNA expression of gfp (c). (b-c: day 1, 4, 7 n=4; day 14 n =2).  (d-f) 
Oscillations in intracellular Ca2+ concentration demonstrated the rhythmic pacemaker activity in MACS+ 
and P-MACS+ ICC cultures and their frequency were measured. (d) Ca2+ oscillation frequency of 
MACS+ cells cultured on STO cells or Ge at day 7 (n ≥ 5). (e) Ca2+ oscillation frequency of 60k MACS+ 
and 60k P-MACS+ cells cultured on STO cells at day 7, and the frequency of 15k MACS+ cells cultured 
on STO cells at day 14 (n ≥ 5). (f) Representative time-course change in fluorescence intensity due to 
Ca2+ oscillation of ICC in the culture of MACS+ cells on STO cells at day 7 (Supplementary Video 1). 
*Samples were normalized to de-epithelialized intestine. Error bars, s.d. *** P < 0.0001, * P < 0.05.  
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Figure 3 | Application of MACS+ cells cultured on STO cells. (a) Confocal images of ICC markers, Kit 
(red), Ano1 (green), and co-localization (yellow). 15k MACS+ cells were cultured on STO-seeded ePCL 
scaffold for 14 days. Scale bar, 100 µm. (b-c) Quantification of Kit alignment expressed by 15k MACS+ 
cells cultured on STO-seeded ePCL and glass for 14 days. (b) Immunofluorescence of ICC markers, Kit 
(red) and Ano1 (green) and with co-localization (yellow). Scale bar, 200 µm. (c) Coherency analysis of 
Kit expression of MACS+ cells cultured on ePCL(aligned) and glass (random), where higher coherency 
means greater cell alignment (n=5).  (d-e) GFP+ MACS+ cells were cultured on STO cells for 4 days and 
purified using MACS before colonoscopic injection into the submucosa of the rectum of C57BL/6 mice. 
A permanent carbon ink was mixed into the cell suspension to mark injection sites. The injected rectums 
were retrieved after 7 days, and were immunostained for Ano1 (d, red), α-SMA (e, red) and GFP (d, e, 
green). GFP co-localized with Ano1 (d, yellow) but not with α-SMA (e). Merged immunofluorescence 
images (left) were further merged with phase contrast images to show the area of injection indicated by 
black ink (right). Scale bar, 100 µm. Error bars, s.d. *** P < 0.0001. 
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Figure 4 | Maintenance of intestinal smooth muscle cell mixture (ISMC Mix) cultured on STO cells in 
vitro over time. Non-sorted cells from enzymatically digested intestinal muscle strips were used. All 
ISMC Mix were cultured in FBS medium for the first 4 days followed by FBS or F12 medium. (a-c) 100k 
ISMC Mix were cultured on STO cells or Ge with FBS or F12 medium for up to 3 weeks. (a) 
Immunofluorescence of ISMC Mix with ICC markers showing co-localization (yellow) of  Kit (red) and 
Ano1 (green), SMCs marker MHC (red), and neuronal marker β-tubulin (green) at day 7. Scale bar, 100 
µm. (b) GFP+ ISMC Mix were analyzed for mRNA expression (Kit, Myh11, Tubb3, Kitl, and Acta2) and 
gfp DNA (n=3). (c) Spontaneous contraction demonstrated the functionality of ISMC Mix cultured on 
STO cells with FBS or F12 medium (Supplementary Video 2,3) and frequency was measured (n ≥ 5). 
FBS = 15% FBS in DMEM. F12 = advanced DMEM/F12. *Samples were normalized to de-epithelialized 
intestine. Error bars, s.d. *** P < 0.0001, * P < 0.05. 
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Figure 5 | Engineering aligned intestinal smooth muscle with periodic contraction over 10 weeks in vitro. 
100k ISMC Mix were cultured on STO cells seeded ePCL scaffolds in FBS medium for the first 4 days 
before changing to F12 medium. (a) Confocal images of ISMC Mix with ICC markers showing co-
localization (yellow) of Kit (red) and Ano1 (green), SMCs marker MHC (red), neuronal marker β-tubulin 
(green), and GFP (green) at 10 weeks. Scale bar, 100 µm. (b) GFP+ ISMC Mix were analyzed for mRNA 
expression (Kit, Myh11, Tubb3, Kitl, and Acta2) (n=5) and gfp DNA (n=4). The dashed line indicates the 
seeding density. (c-e) Relaxed and contracted state comparison of engineered intestinal smooth muscle. 
(c) Images of GFP expression from ISMC Mix seeded ePCL scaffold were extracted from a video 
recording and outlined (relax, black; contract, gray) for comparison. Scale bar, 2mm (Supplementary 
Video 4).  (d) To show the degree of the periodic contraction, area of contracted ePCL scaffolds were 
normalized to that of relaxed ePCL scaffolds (n = 10).  (e) To show the directionality of the periodic 
constriction, height and width of contracted ePCL scaffolds were normalized to those of relaxed ePCL 
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scaffolds (n = 10).  (f) Frequency of ePCL rhythmic contractions (n = 4). The dark gray dashed line 
indicates the mean frequency over time and light gray dashed lines indicate its s.d. *Samples were 
normalized to de-epithelialized intestine. Error bars, s.d. *** P < 0.0001, * P < 0.05. 
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Figure 6 | MACS+ cells’ role in cultured ISMC Mix with rhythmic contractions in vitro. (a-c) 100k 
MACS0 (passaged ISMC Mix: mixture of MACS+ cells, SMCs and neuronal cells) or MACS- cells 
(ISMC Mix without MACS+ cells: mostly SMCs and neuronal cells) were cultured on STO cells for 3 
weeks. Cells were seeded and cultured in FBS medium for the first 4 days before changing to F12 
medium. (d-f) 100k MACS- were seeded on STO cells for 5 weeks, with (MACS-/+) or without (MACS-
) addition of 60k MACS+ cells on day 5. Cells were cultured in FBS medium for the first 7 days before 
changing to F12 medium. (a, d) Confocal images of ICC markers, Kit (red), Ano1 (green), co-localization 
(yellow). Scale bar, 100 µm. (b, e) Frequency of cultured cells motility due to spontaneous contraction (b: 
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wk2 n=2, wk3 n=4; e: wk5 n=4). (c, f) Cultured cells were analyzed for mRNA expression (Kit, Myh11, 
Tubb3) at week 2 (c) or week 5 (f) (n=4). *Samples were normalized to de-epithelialized intestine. Error 
bars, s.d. *** P < 0.0001, ** P < 0.01, * P < 0.05. 
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3.8 SUPPLEMENTARY FIGURES 
 
Supplementary Figure 1 | Comparison of MACS+ cells cultured on STO cells, MEF cells, and gelatin in 
vitro. Immunofluorescence of ICC markers: Kit (red) and Ano1 (green) and with co-localization (yellow), 
and nuclear marker DAPI (blue).  60k MACS+ cells on different substrates and feeder cells alone (STO, 
MEF: controls) were cultured for 7 days. Scale bar, 200 µm. STO = Mouse Embryonic Fibroblast (Santos 
Inbred Mouse, SIM). MEF = Mouse Embryonic Fibroblast (C57BL/6).  Ge = gelatin coating. Feeder cells 
(STO, MEF) were mitomycin C treated.  
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Supplementary Figure 2 | Comparison of STO and MEF feeder cells cultured in vitro over time. 100k 
feeder cells were seeded on gelatin in STO medium overnight and cultured in FBS medium for 7 days. (a) 
Phase contrast images of the feeder cells. Scale bar, 100 µm. (b) Immunofluorescence of feeder cells with 
Kit ligand marker SCF (green), cytoskeleton marker phalloidin (red), and nuclear marker DAPI (blue). 
Scale bar, 200 µm. (c) Comparison of the size of feeder cells suspended in medium at day 0 before 
seeding. Phase contrast images were taken for cell area comparison. Area of MEF cells were normalized 
to that of STO cells (n=70 cells; *** P < 0.0001). Scale bar, 100 µm. (d-e) Feeder cells were compared 
for their kitl mRNA expression at day 0 as a cell suspension (d: n=3; triplicate samples) and at day 7 of 
culture (e: n=4; quadruplicate samples). *** P < 0.001. FBS = 15% FBS in DMEM. *Samples were 
normalized to de-epithelialized intestine. Error bars, s.d.    
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Supplementary Figure 3 | Cell alignment in the native murine small intestine. (a) Confocal images of 
immunofluorescent murine muscle strips with ICC markers showing co-localization (yellow) of Kit (red) 
and Ano1 (green), neuronal marker β-tubulin (green) and SMCs marker MHC (red). Scale bar, 50 µm. (b) 
Scanning electron micrographs of ePCL scaffold. The fiber alignment of ePCL scaffold was used to 
induce cell alignment. Scale bar, 25 µm. Muscle = muscle layer of murine small intestine.  Plexus = 
myenteric plexus of murine small intestine. 
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Supplementary Figure 4 | Viability of mitomycin C treated STO cells in vitro over time. 100k STO cells 
were cultured under the same conditions as with ISMC Mix co-culture. Cells were seeded on gelatin in 
STO medium overnight and cultured in FBS medium for 4 days followed by F12 medium. Phase contrast 
images and MTS assay measurements (n=3; triplicate samples; error bars, s.d.) were taken at each time 
point. Scale bar, 100 µm. F12 = advanced DMEM/F12. 
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Supplementary Figure 5 | Alignment quantification of infiltrated ISMC Mix inside ePCL scaffolds at 10 
weeks. Non-sorted cells from enzymatically digested intestinal muscle strips, ISMC Mix, were cultured 
on STO-seeded ePCL scaffolds. 100k ISMC Mix were cultured in FBS medium for the first 4 days before 
changing to F12 medium.  ePCL scaffolds were cut in two orthogonal planes to expose cross section (CS) 
parallel or perpendicular (perpen) to ePCL’s aligned fibers. (a) Confocal images of immunostained ISMC 
Mix with SMCs marker MHC (red), GFP (green), neuronal marker β-tubulin (red), and nuclear marker 
DAPI (blue) in parallel and perpendicular cross sections. Scale bar, 50 µm. (b) Coherency analysis 
(MHC, GFP and β-tubulin) and circularity analysis (DAPI) of infiltrated ISMC Mix inside ePCL 
scaffolds (n = 3). Coherency analysis = range from 0 (perfect random) to 1 (perfect alignment) indicating 
cell alignment. Circularity analysis = range from 0 (most elongated shape) to 1 (perfect circle) indicating 
elongation of nuclei due to cell alignment. *Samples were normalized to de-epithelialized intestine. Error 
bars, s.d. *** P < 0.0001, ** P < 0.01. 
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function multiROI() 
  
[filename,filepath,~] = uigetfile('*.*',  'All Files (*.*)'); 
  
video_handle = VideoReader(fullfile(filepath, filename)); 
  
reference_frame = read(video_handle, 1); 
frame_num = video_handle.NumberOfFrames; 
  
% compute an average intensity change map 
average_intensity_change = zeros(video_handle.Height, video_handle.Width); 
for frame_idx = 1 : frame_num 
    curr_frame = read(video_handle, frame_idx); 
    average_intensity_change = average_intensity_change + 
im2double(curr_frame(:, :, 2)); 
end 
average_intensity_change = average_intensity_change ./ frame_num; 
  
  
%figure(1), subplot(121); imshow(reference_frame); 
figure(1), imagesc(average_intensity_change); axis image; 
  
roi_num =input('Input the number of ROIs you want to select in this video:'); 
roi_masks = cell(roi_num, 1); 
roi_images = cell(roi_num, 1); 
  
for roi_idx = 1 : roi_num 
    message = sprintf('%d out of %d ROI. Left click and hold to begin 
drawing.\nSimply lift the mouse button to finish',... 
        roi_idx, roi_num); 
    uiwait(msgbox(message)); 
    hFH = imfreehand(); 
    roi_masks{roi_idx} = hFH.createMask(); 
    pos = hFH.getPosition(); 
     
    % define bounding box 
    x1 =  max(1, min(round(min(pos(:,2))), video_handle.Height)); 
    y1 =  max(1, min(round(min(pos(:,1))), video_handle.Width)); 
    x2 =  max(1, min(round(max(pos(:,2))), video_handle.Height)); 
    y2 =  max(1, min(round(max(pos(:,1))), video_handle.Width)); 
     
    roi_image_r = reference_frame(:, :, 1) .* uint8(roi_masks{roi_idx}); 
    roi_image_g = reference_frame(:, :, 2) .* uint8(roi_masks{roi_idx}); 
    roi_image_b = reference_frame(:, :, 3) .* uint8(roi_masks{roi_idx}); 
    roi_images{roi_idx} = cat(3, ... 
        roi_image_r(x1:x2, y1:y2), ... 
        roi_image_g(x1:x2, y1:y2), ... 
        roi_image_b(x1:x2, y1:y2)); 
end 
  
fprintf('Start processing.\n'); 
average_intensity = zeros(frame_num, roi_num); 
average_interval = 1.0 / video_handle.FrameRate; 
77 
 
for i = 1 : frame_num 
    raw_frame = read(video_handle, i); 
    green_channel = double(raw_frame(:, :, 2)); 
    % abandon red and blue channel, because mostly no data is available 
    for roi_idx = 1 : roi_num 
        average_intensity(i, roi_idx) = 
mean(green_channel(roi_masks{roi_idx})); 
    end 
end 
  
% filter out the first dark period 
thres = mean(average_intensity) - 3 * std(average_intensity); 
  
valid_frame_indices = zeros(roi_num, 1); 
for roi_idx = 1 : roi_num 
    indices = sort(find(average_intensity(:, roi_idx) >= thres(roi_idx)), 
'ascend'); 
    valid_frame_indices(roi_idx) = indices(1); 
end 
  
for roi_idx = 1 : roi_num 
    figure; hold on; 
    title(sprintf('ROI %d', roi_idx)); 
    subplot(231); imagesc(roi_images{roi_idx}(:, :, 2)); axis image; 
title(sprintf('Image ROI %d', roi_idx)); 
    axis off; 
  
    truncated_average_intensity = 
average_intensity(valid_frame_indices(roi_idx):end, roi_idx) %; want to know 
this number 
    truncated_timestamps = [valid_frame_indices(roi_idx) : frame_num] .* 
average_interval;  
     
    truncated_timestamps' 
     
    Y = fft(truncated_average_intensity); 
    n=length(Y); 
    Y=Y(1:ceil(n/2)); 
    n=length(Y); 
    mY=abs(Y); 
     
    subplot(233); hold on; 
    FREQ=(0:n-1)*(video_handle.FrameRate /(2*n)); 
    semilogy(FREQ, mY); 
    xlabel('Frequency (Hz)'); 
    title('Periodogram of Depolarization'); 
  
    subplot(232); hold on; 
    xlabel('Time (seconds)'); 
    ylabel('Intensity (percent)'); 
    title('Mean Intensity Over Time'); 
  
    plot(truncated_timestamps, truncated_average_intensity); 
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    % Establish characteristics of the FFT (Periodogram) of the intensity 
plot 
    % of depolarizing cells.  This plot is the top right image. 
  
    % I also create a zero-centered Periodogram for easier visualization.  
This 
    % plot is on the bottom left figure. 
    Z=fftshift(mY); 
    f0 = (-n/2:n/2-1)*.5*(video_handle.FrameRate/(length(Y)));  % 0-centered 
frequency range 
    subplot(235); hold on; 
    plot(f0,Z); 
    xlabel('Frequency (Hz)'); 
    title('Zero-shift Periodogram of Depolarization'); 
  
    [pks,locs] = findpeaks(Z); 
    [pkvals,idx] = sort(pks,'descend'); %sort to vector 
    pkvals(2); %second largest value - the first is always 0 and doesn't mean 
anything 
    index=find(Z==pkvals(2)); 
    mainFrequencyStr=num2str(f0(index)); 
    plot(f0(index),Z(index),'r.', 'MarkerSize',25); 
    text(f0(index),Z(index),['Frequency = ',mainFrequencyStr, ' Hz']); 
    Frequency = f0(index); 
    axis([0 ceil(10*f0(index)) 0 ceil(2*pkvals(2))]); 
    fprintf('ROI %d: Frequency %f Hz\n', roi_idx, f0(index)); 
  
    % I do the same thing for the inverse of the frequency, aka the period. 
    period=1./FREQ; 
    subplot(236); hold on; 
    plot(period,mY); 
    [pks2,locs2] = findpeaks(mY); 
    [pkvals2,idx2] = sort(pks2,'descend'); %sort to vector 
    pkvals2(1); % largest value 
    index2=find(mY==pkvals2(1)); 
    mainPeriodStr=num2str(period(index2)); 
    plot(period(index2),mY(index2),'r.', 'MarkerSize',25); 
    text(period(index2),mY(index2),['Period = ',mainPeriodStr, ' Seconds']); 
    xlabel('Period (seconds)'); 
    axis([0 ceil(2*period(index2)) 0 ceil(2*pkvals2(1))]); 
    fprintf('ROI %d: Period %f seconds.\n', roi_idx, period(index2)); 
end 
end 
 
Supplementary Figure 6 | Matlab code for analyzing Ca2+ oscillation videos. Multiple regions of interest 
(ROIs) can be selected and the average fluorescent intensity within the selected regions is calculated for 
each frame. Outputs include time-course change in fluorescence intensity, frequency and period for each 
selected ROI.  
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%Reset everything 
clear all; 
close all; 
  
bordervector = [0 16 30 34 48 64]; 
colorscale=zeros(64,3); 
  
for j=1:64 
    if bordervector(1)<=j && j<=bordervector(2) 
        colorscale(j,1)=0; 
        colorscale(j,2)=0; 
        colorscale(j,3)=1; 
    end 
     
    if bordervector(2)<j && j<=bordervector(3) 
        scale1=((j-15)*18)/270; 
        colorscale(j,1)=scale1; 
        colorscale(j,2)=scale1; 
        colorscale(j,3)=1; 
    end 
     
    if bordervector(3)<j && j<=bordervector(4) 
        colorscale(j,:)=1; 
    end 
     
    if bordervector(4)<j && j<=bordervector(5) 
        scale2=(255-((j-34)*18))/255; 
        colorscale(j,1)=1; 
        colorscale(j,2)=scale2; 
        colorscale(j,3)=scale2; 
    end 
     
    if bordervector(5)<j && j<=bordervector(6) 
        colorscale(j,1)=1; 
        colorscale(j,2)=0; 
        colorscale(j,3)=0; 
    end 
end 
  
% Note: a large portion of this code was directly taken and modified 
% from code used in "Smooth muscle strips for intestinal tissue engineering" 
% by Chris Walthers. 
  
%Ask user to choose a file to run.  This should be a .wmv file.  If it is 
%not, you can easily convert with Windows Live Movie Maker 
[FileName,PathName,filterindex] = uigetfile('*.*',  'All Files (*.*)'); 
  
%The following allows you to shorten the video produced by this code. 
framenum=input('How many frames do you want to skip between each frame 
captured? (Must be greater than 0)  '); 
fps=30; %frames per second; wmvs are always 30 
sample=fps/(framenum); %establish how many frames per second new video will 
have, important for the FFT part 
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% Saves the new video in the same folder as the input video 
outputFolder = PathName; 
  
% Read in the movie. 
mov = VideoReader(FileName); 
new_FileName = strrep(FileName, '.wmv', '_CAcode_output'); 
  
% Determine how many frames there are, and pixels, and final number of 
% frames 
nFrames = mov.NumberOfFrames; 
videoHeight = mov.Height; 
videoWidth = mov.Width; 
newframes=floor(nFrames/(framenum+1)); 
  
% Preallocate movie structure. 
movie1(1:newframes) = struct('cdata', zeros(videoHeight, videoWidth, 3, 
'uint8'), 'colormap', []); 
  
% % Read one frame at a time. 
for k = 1 : newframes 
    movie1(k).cdata = read(mov, k*(framenum+1)-framenum+1); 
end 
  
%Preallocate structure for subsequent structures 
greendata=zeros(videoHeight,videoWidth,newframes); 
subtracted=zeros(videoHeight,videoWidth,(newframes-1)); 
  
for l=1:newframes 
greendata(:,:,l)=movie1(l).cdata(:,:,2); 
end 
  
% Display the freehand mask in a 6 panel window with some cool extra figures 
figure('units','normalized','outerposition',[0 0 1 1]); 
workspace;  % Make sure the workspace panel is showing. 
fontSize = 16; 
  
% colormap(colorscale); 
% colormap jet; 
colormap gray; 
colormap(flipud(colormap)); 
% colormap(flipud(colormap)); 
%Do some housekeeping 
  
clear movie1; 
  
% Prepare the new video file. 
% New file will have same file name as before, but with _CAcodeFFT.avi at 
% the end. 
% vidObj = VideoWriter(new_FileName,'Uncompressed AVI'); 
vidObj = VideoWriter(new_FileName,'Motion JPEG AVI'); 
open(vidObj); 
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% This is a "for loop" that subtracts the first image in the video from all 
% subsequent images.  In effect, this "normalizes" every frame of the video 
% to the first frame (arbitrarily... you could do the same with any frame 
% from the video for similar effect).  Now the new video will show changes 
% in intensity from the first frame. 
% colormap(colorscale); 
  
  
for m=2:newframes 
subtracted(:,:,m)=imsubtract(greendata(:,:,m), greendata(:,:,3)); 
image((subtracted(:,:,m))+31); 
currFrame=getframe; 
writeVideo(vidObj,currFrame); 
end 
  
% This line makes it easier to view stills from your video exactly as they 
% appear in the video 
subtracted=subtracted+31; 
  
% % % This code plays a series of stills for reviewing your video after 
% making it 
% % selectImage = implay(subtracted); 
% % selectImage.Visual.ColorMap.UserRangeMin=0; 
% % selectImage.Visual.ColorMap.UserRangeMax=64; 
% % selectImage.Visual.ColorMap.UserRange = 1; 
% % set(findall(0,'tag','spcui_scope_framework'),'position',[100 150 
(videoWidth)*1.1 (videoHeight)*1.1]); 
  
% Close the file. 
close(vidObj); 
% Housekeeping 
% clear greendata; clear subtracted; 
 
Supplementary Figure 7 | Matlab code for processing Ca2+ oscillation videos. Original video can be 
condensed by capturing only every nth frame (every 3th frame was used to produce supplementary video 
1). The intensity values from the first frame in the video are subtracted as baseline intensity from each 
subsequent frame to create a normalized intensity profile compared to the first frame. Changes in 
fluorescent intensity, corresponding to calcium concentration, are color-mapped to show in grayscale with 
an increase in black, decrease in white, or no change in gray relative to the first frame.  
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3.9 SUPPLEMENTARY VIDOES 
 
Supplementary Video 1 | Ca2+ oscillation of ICC in the culture of MACS+ cells on STO at day 7. The 
original video was processed with matlab so that it is about three times faster than the real time and color 
normalized to the first frame of the video, where higher intensity shows up lighter and lower intensity 
shows up darker.  
 
Supplementary Video 2, 3 | ISMC Mix without GFP expression (2) and with GFP expression (3) 
cultured on STO cells in vitro for a week.  
 
Supplementary Video 4 | ISMC Mix were cultured on STO cells seeded ePCL scaffolds for 8 weeks.  
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CHAPTER FOUR: CONCLUSIONS AND FUTURE DIRECTIONS 
 
4.1 IDENTIFY A FEEDER-FREE CULTURE SYSTEM FOR INTESTINAL SMOOTH 
MUSCLE ENGINEERING  
The objective of this project was to identify the culture system to maintain functional ICC for 
functional smooth muscle tissue engineering. This was achieved by using a feeder layer culture 
system with standard medium (Chapter 3). However, it is ideal to pursue a feeder-free culture 
system for the intestinal tissue engineering purpose. In order to achieve this goal, the following 
two aspects were considered: 1) what STO cells were secreting into the medium, which lead to 
media optimization, and 2)  what STO cells were expressing on the cell surface, which lead to 
substrate optimization. 
 
4.1.1Media optimization: necessity of STO cells conditioned media?  
STO cells are known to secret many factors and commonly used for in vitro maintenance and 
growth of embryonic stem cells and induced pluripotent stem cells. Examples of growth factors 
abundantly present in conditioned medium of the STO cells (STO-CM) are activin A, insulin-
like growth factor 1(IGF-1), insulin-like growth factor 2(IGF-2), macrophage colony-stimulating 
factor (M- CSF), and pigment epithelium-derived factor (PEDF), but particularly more 
hepatocyte growth factor (HGF), and SCF1. Also, it should be noted that STO cells lacks 
expression of EGF and FGF family members1. We already showed that exogenous addition of 
SCF failed to support ICC growth any better (with higher ICC seeding density at 60k), and that 
STO-CM was only helpful to increase Kit expression of ICC culture with lower seeding density 
at 15k but not with higher seeding density at 60k (Chapter 3). Therefore, the effect of STO-CM 
for ISMC Mix containing ICC, SMC and neuronal cells might be also limited. Yet, it is worth 
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investigating as a part of effort to achieve feeder-free culture system because there are cases in 
which conditioned media is effective. For example, previous work in our group demonstrated 
that intestinal subepithelial myofibroblasts conditioned media enhanced the growth of intestinal 
crypts2. 
 In preliminary experiments, the STO media (Chapter 3) was replaced about one day after 
mytomycin C treatment of confluent STO monolayer. The F12 medium (Chapter 3) was 
collected after 3~4 days of incubation, passed through a 0.2 mm pore size filter, and used as 
STO-CM stock. The cell cultures grown with STO-CM were given media composed of STO-CM 
stock and the fresh F12 medium (Chapter 3) in a 1:1 ratio. When ISMC Mix (Chapter 3) were 
grown on gelatin, the improvement made by STO-CM in ICC marker Kit and Ano1 
colocalization, SMCs marker MHC, and neuronal marker β-tubulin was obvious compared to 
FBS medium (Chapter 3), yet not noticeable compared to F12 medium. The STO cells were 
much more effective in preserving the ICC population within the ISMC Mix culture by securing 
not only ICC but also other types of cell attachment, and soluble factors in STO-CM could not 
meet the level of the effectiveness of STO cells. Therefore, the necessity of STO-CM when F12 
medium is used as base medium is currently under investigation. These preliminary results of 
STO-CM lead us to investigate in optimizing a substrate for better cell attachment and initial cell 
survival. 
 
4.1.2 Substrate optimization: SCF immobilized ePCL scaffolds  
SCF exists as two distinct isoforms of transmembrane proteins expressed on the cell surface3. 
Soluble SCF (sSCF) undergoes rapid proteolytic cleavage and  release from the plasma 
membrane, while membrane-bound SCF (mSCF) releases sSCF much more slowly due to the 
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lack of the proteolytic cleavage site4. Consequently, both isoforms originally exist as mSCF and 
the main difference is the rate of cleavage and release of biologically active sSCF. Both isoforms 
seem to play a specific physiological role because the ratio of the two varies in different tissues3. 
It was found that mutant mice only expressing sSCF but no mSCF failed to exhibit a 
spontaneous, rhythmic electrical slow wave, and ICC-MY were absent in the myenteric plexus 
5,6. This suggests that mSCF may have a crucial role for the development and maintenance of 
ICC-MY. In addition, stimulation of Kit with mSCF in Mo7E (SCF-dependent myeloid cell line) 
activated Kit receptor more persistently than stimulation with sSCF 7. Therefore, mSCF may 
activate Kit on ICC more effectively than sSCF. A previous study demonstrated that a SCF 
immobilized substrate supported the proliferation of Mo7E cells8. To my knowledge, no one has 
developed a suitable scaffold that can induce functional ICC and SMC proliferation and/or 
maturation. Since feeder cells used in our ICC culture system may not be compatible with the 
host animal/patient, it will be critical to develop implantable scaffolds to support ICC 
proliferation and maturation for intestinal muscle engineering.  
In preliminary experiments, ePCL scaffolds were used to induce ICC and SMC alignment 
and network formation. In order to mimic mSCF, SCF were immobilized on the surface of ePCL 
by using sulfo-sanpah chemistry, which was the same procedure used to improve the 
hydrophilicity of a PDMS surface9. Several surface treatments of ePCL tested include plasma 
etching10 (plasma-ePCL), UV irradiation11 (UV-ePCL), (3-Aminopropyl)triethoxysilane (APTS) 
conjugation (NH2-ePCL), sulfo-sanpah conjugation (COOH-ePCL), SCF conjugation (mSCF-
ePCL), and gelatin coating. Plasma etching (air plasma for 1min) was very effective in making 
ePCL hydrophilic for later sulfo-sanpah conjugation containing strong UV irradiation in its 
procedure and for gelatin coating. Unfortunately, there was no noticeable difference in cell 
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attachment and ICC markers Kit and Ano1 expressions among MACS+ cells seeded on mSCF-
ePCL, COOH-ePCL and NH2-ePCL. The effort of improving SCF conjugation procedure by 
increasing the concentration of SCF solution from 1ug/ml to 10ug/ml and adding the SCF 
solution right after the sulfo-sanpah conjugation to the ePCL failed to enhance ISMC Mix 
attachment to mSCF-ePCL compared to plasma-UV-ePCL, COOH-ePCL and NH2-ePCL. 
  According to previous studies, Kit receptor dimerization is necessary for effective 
activation of protein kinase activity and its downstream signaling pathway for ICC development. 
Also, the non-covalent homodimeric form of SCF stimulates cell growth more effectively than 
monomeric SCF 12,13. In order to make mSCF-ePCL effective for ICC attachment and 
proliferation, not only the amount but also the orientation and formation of SCF conjugated to 
the ePCL may matter. Ideally, ePCL with enough homodimeric SCF immobilizion with its Kit 
binding site exposed should effectively activate Kit receptor dimerization for ICC to survive. 
Therefore, many factors still need to be considered for the substrate optimization.  
 
4.2 CONCLUDING REMARKS 
Although the media and substrate optimization efforts alone have not shown conclusive results, 
the combination of the two optimized system might bring some synergetic effect in improving 
not only ICC but also the whole ISMC Mix attachment and survival in vitro. Yet, the media and 
substrate optimization we mentioned above is all about chemical stimulation. We also need to 
consider the effect of mechanical stimulation on functional intestinal tissue engineering as a 
whole. For example, application of mechanical stress is known to induce mature phenotype of 
SMC, including higher MHC expression. Not only can a bioreactor with an automated program 
impose mechanical stress on seeded cells, but also the substrate with varying stiffness can have a 
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significant effect. If our purpose is to induce higher MHC expression of SMC, the stiffer the 
substrate is the more effective it is. However, we have to keep in mind that in order to 
bioengineer functional intestinal smooth muscle, SMC as well as all the other types of cells 
including ICC and neuronal cells in the ISMC Mix need to be functional and mature. In contrast 
to SMC, it is well known that neuronal cells survive and mature better on softer substrates. 
Therefore, there should be an optimal substrate stiffness for ISMC Mix culture as a whole entity.  
The STO cells proved its ability to maintain not only ICC but also SMC populations 
functional (Chapter 3). The in-depth investigation of why and how the STO culture system 
enables the engineering of ISMC Mix into functional smooth muscle with spontaneous rhythmic 
contraction in vitro might give us the missing puzzle pieces to overcome challenges in the 
current optimization for achieving the feeder-free culture system. If people with a deep 
understanding of biomaterial, bioconjugation and molecular biology work hard together to solve 
the puzzle, the feeder-free implant that mimics interstitial smooth muscle structurally and 
functionally should be accomplished in near future. Finally, the knowledge gained in 
bioengineering functional intestinal smooth muscle should be widely applicable to other types of 
smooth muscle in other visceral organs, contributing to the entire tissue engineering and 
regenerative medicine field to move forward.  
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